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ABSTRACT 
 
The health and viability of cells and tissues in the human body depend on 
the functional integrity of proteins. A small number of long-lived proteins, 
including the crystallins in the lens of the eye, evade protein turnover, a typical 
cellular mechanism for repair and regeneration, and remain extant throughout 
life. The cumulative effect of post-translational modifications on the structure, 
function, and conformation of these long-lived proteins records the history of 
molecular aging in an individual. Along with absence of protein turnover, the 
optical accessibility, transparency, and age-related spatial order make the lens 
an ideal target for in vivo assessment of molecular aging. Accordingly, this 
doctoral thesis investigated the hypothesis that age-related perturbations that 
alter the protein environment in the human lens can be detected and monitored 
as a quantitative biomarker of molecular aging detectable by quasi-elastic light 
scattering (QLS). 
To test this hypothesis, QLS was applied in vitro and in vivo to study time-
  x 
dependent changes in lens proteins. Water-soluble human lens protein extract 
was used in vitro as a model system that mimics the lens fiber cell cytoplasm. 
The effects of long-term incubation (nearly one year, proxy for aging), oxidative 
stress, ionizing radiation, metal-protein and pathogenic protein-protein 
interactions were investigated by QLS as a function of time. In vitro results were 
validated by protein gel electrophoresis and transmission electron microscopy. In 
vivo, age-dependent changes in lens proteins were assessed in healthy subjects 
across a broad age-range (5–61 years of age). Pathogenic protein aggregation in 
the lens was examined in vivo using Down syndrome (DS) subjects, a common 
chromosomal disease associated with an age-related Alzheimer’s disease (AD)-
linked lens phenotype. 
Results obtained from the in vitro studies noted, for the first time, QLS 
detection of long-term supramolecular changes in a complex lens protein model 
system. Our FDA-approved QLS device was successful in assessing age-
dependent lens protein changes in a clinical study at Boston Children’s Hospital 
(BCH). In two landmark studies conducted at BCH, we detected statistically 
significant AD-related lens protein changes in DS subjects aged 10–20 years, 
when compared with age-matched controls. These studies are the first clinical 
application of QLS in DS, and demonstrate protein changes in DS earlier than 
any previously reported studies.  
  xi 
Due to the discrepancy in chronological and biological age and the lack of 
an objective index for the latter, we propose the application of QLS in the human 
lens as a quantitative biomarker of molecular aging. 
  
  xii 
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Chapter 1 
 
Introduction 
 
1.1 The Lens as a Study Model 
1.1.1 Growth and Development 
The lens of the eye is an exquisite and unique tissue system that grows 
throughout the life of an organism and lives beyond its death. Owing to the 
characteristic growth pattern, composition, and optical accessibility, the lens 
offers an ideal system to study the effects of aging [1–19]. Within the eye, it is 
suspended by zonular fibers between the aqueous humor and the vitreous humor 
layers, and is surrounded by a capsule (Figures 1.1 and 1.2). The lens capsule is 
an elastic membrane and allows the passage of nutrients, such as oxygen, 
glucose, amino acids, fatty acids, from the aqueous humor into the lens, and 
lactate and carbon dioxide out of the lens. The capsule is impermeable to most 
proteins and of importance in accommodation. The major protein of the capsule 
is collagen [20].  
  The lens is avascular; it is derived from the ectodermal germ line of cells 
and is composed of this cell type in various differentiated forms. The outer 
epithelial monolayer of the lens is the only cell population with mitotic activity [2] 
(Figure 1.2).  
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Figure 1.1: Schematic of the human eye [21] 
 
 
 
 
Figure 1.2: Cross-sectional view of the human lens [21] 
 
Human lens development starts at approximately the 28th day of gestation 
with the thickening of the surface ectoderm, near the optic vesicle, to generate 
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the lens placode. This is followed by generation of the lens vesicle, with the 
vesicle’s formation being completed by day 56 [22]. Further growth takes place 
from the lens germinative zone, which is the anterior portion of the epithelial 
layer. Cells in this region undergo mitosis and migrate to the transitional zone 
(posterior to the equator) where they differentiate and elongate into fiber cells 
that pack tightly into quasi-hexagonal arrays [22, 23]. The organization of new 
cells is in concentric shells over older cells. During this process of differentiation 
and elongation, large quantities (0.2–0.4 g/ml of cellular volume) of structural 
proteins called crystallins are synthesized within the fiber cells [23]. This is 
followed by loss of cellular organelles and compaction of the fiber cells, resulting 
in the cessation of metabolic activity in the mature fiber cells. Development of 
lens fiber cells through the above process continues throughout life, with the 
older cells being packed in the center of the lens [22–24]. There is no shedding 
of cell layers, loss of cell contents, or generation of new proteins in the fiber cells. 
As a result, the developmental history of the lens can be followed from the core 
(nucleus) to the periphery (cortex) [20, 22, 23].  
The growth of the human lens has been found to be biphasic; prenatally, 
growth is asymptotic, and postnatally, it is linear. This results in the formation of 
two major regions with different properties – the nucleus and cortex (Figure 1.2). 
The fiber cells in the nuclear core are formed prenatally while the cortex gets 
generated during the postnatal phase [22, 24]. The cells in the nuclear region are 
generally larger in size compared to the cells in the cortex. As the lens grows, 
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there is compaction of fiber cells, which lasts till about 60 years after birth. 
Compaction is associated with loss of water and reduction of extracellular space 
[24], which is a factor in concentrating the protein mixture to provide the required 
high refractive index and increasing local order of cellular organization. Although 
there are varying results in literature regarding percentage of water content in the 
nucleus and cortex, the average lens dry weight concentration increases from 
about 17% at birth to about 30% by 3 months after birth, and then increases 
slowly over lifetime to about 35%. The dry mass concentration in the nuclear 
region is 2–3 fold that of the cortex in an aged lens, suggesting that modifications 
of the nuclear complement of proteins might be instrumental in reducing bound 
water [25, 26]. Another change that occurs as the lens grows and ages is in its 
stiffness. There is a large increase in stiffness, or hardening, in all parts of the 
lens tissue, mostly after the age of 20 years, and studies have indicated that this 
might also be due to protein interactions and post-translational protein 
modifications, causing water loss and insolubilization of protein species [24, 27, 
28].  
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1.1.2 Composition 
 
There are three major classes of crystallin proteins in the mammalian lens 
- α,β, and γ [12, 20, 29], which make up about 35% of the wet weight of the lens 
[12, 30]. A requirement for high concentration is high solubility, and consequently 
water-soluble crystallins constitute up to 90% of the lens’ protein content [12]. 
The α-crystallins are composed of 2 primary subunits, held together by 
hydrophobic linkages and hydrogen bonds [12], αA (acidic) and αB (basic), each 
with molecular weights near 20 kDa. They belong to the family of small heat-
shock proteins (sHSP) and are one of the most conserved proteins from an 
evolutionary standpoint [31]. sHSP are a family of proteins produced by cells in 
response to stress as well as for their role as molecular chaperones [13], which 
refers to the ability to bind to partially unfolded proteins and mitigating 
aggregation cascades. 
This α-crystallin class is characterized by its propensity to form a 
heterogeneous array of large aggregates, ranging from 200 kDa to upwards of 
800 kDa [12, 29, 30, 32, 33], and comprise about 35% of the total crystallins in 
the lens [29]. The subunits are products of two genes - αA and αB, which exist in 
a ratio of 3:1 in mammals. They bear close to 60% homology in their sequences 
and have a common ancestor [31]. The αA gene in humans is located on 
chromosome 21 and encodes a 175 amino-acid sequence protein, while the αB 
gene resides on chromosome 11 and encodes a 173 amino-acid sequence 
protein [29]. A primary role played by α-crystallins is as a molecular chaperone, 
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where they bind other partially denatured proteins and prevent aggregation. Out 
of the two subunits, αA is primarily found in lens tissue, while αB is found 
ubiquitously in the body [13, 30]. The β-crystallin family comprises of as many as 
seven different subunits with molecular weights ranging from 22 to 28 kDa, and 
they form aggregates ranging from 50 to 200 kDa [32, 33]. They make up around 
40–50% of the total amount of crystallins in the lens [34]. The major subunits of 
β-crystallins identified in a young human lens are βA1, βA3, βA4, βB1, βB2, and 
βB3 [31]. γ-Crystallins are the third major crystallin type, constituting around 20% 
of the total crystallins in the lens [20, 34]. They can be comprised of up to seven 
different subunits, each with a molecular weight of about 20 kDa and typically 
exist as monomers. The major γ-crystallin forms detected in humans are γC, γS, 
and γD [31]. β and γ crystallins are related in structure and appear to have a 
common microbial stress protein ancestor [13]. 
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1.1.3 Order and Transparency 
The primary function of the lens is to focus and transmit light, and there 
are a number of features that optimize its functionality. The high protein 
concentration in the lens, highest of any tissue in the body [13], provides the 
necessary refractive index, and variations in the distribution and concentration of 
the different crystallin species lead to a gradient of refractive index, increasing 
from periphery to the center. This reduces spherical aberration, and the close 
packing of the fiber cells prevents large discontinuities in the gradient of 
refractive index (Figure 1.3) [23]. The lens, along with the cornea, aqueous and 
vitreous humor, are the only transparent tissues in mammals. Transparency can 
be quantified in terms of the extinction coefficient τ (Equation 1.1) where Io is the 
incident light intensity, It is the transmitted light intensity, and l is the thickness of 
the medium. 𝐼! =    𝐼!𝑒!!"  (1.1) 
 
The biophysical phenomena that affect the extinction coefficient are 
absorption and scattering. Due to the absence of light-absorbing biochemicals, 
absorption of light in the visible spectrum is negligible in the aforementioned 
transparent tissues [23, 35]. Scattering of light can be expected from two major 
components - membranes and proteins. The former displays quasi-periodicity in 
organization with lattice periodicity in the order of several microns, which is much 
larger than the light wavelengths. As a result, the only significant scattering that’s 
expected is Bragg reflections. Additionally, scattering is proportional to the 
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fluctuations in refractive index between the scattering particles and the base 
medium, i.e. the cytoplasm. Since there are a number of proteins associated with 
the membranes, their average refractive index is close to that of the cytoplasm, 
and scattering is thus minimized [22]. The aqueous and vitreous humors do not 
contribute significantly to light scattering since they are predominantly composed 
of water and have low concentrations of macromolecules [34]. It is in the cornea 
and the lens that the issue of transparency needs to be addressed. The cornea is 
largely composed of collagen protein in the form of fibrils within lamellae, and as 
described earlier, the lens has concentrically arranged layers of fiber cells with 
high concentrations of crystallin proteins. Scattering of light off individual particles 
in a dilute solution is described by Rayleigh theory and is directly proportional to 
the mass (M) and concentration (c) of the scattering molecules (Equation 1.2) 
[35]. Is is scattered intensity, Io is incident light intensity, no is index of refraction of 
solvent, dn/dc is the increment of refractive index, Θ is the scattering angle, r is 
the distance from the scatterer, and λ is the wavelength of visible light. 
!!!! = 2𝜋!𝑀𝑐𝑛!! !"!" ! (1+ 𝑐𝑜𝑠!𝜃)/𝑟!𝜆!     (1.2) 
 
If every particle were to act independently and scatter light according to 
equation 1.2, more than 90% of the incident light would be scattered. 
Transparency in both the cornea and the lens is achieved by taking into account 
the correlation in phases of the waves scattered from each fiber and the resulting 
destructive interference [19, 35, 36]. This was first shown for the cornea where 
the collagen fibers are spaced by distances that are small compared to the 
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wavelength of light. This causes considerable correlation between the phases of 
light and reduces the intensity of scattered light significantly. Furthermore, light is 
scattered only from those fluctuations in the index of refraction with wavelengths 
greater than one half of the wavelength of light in the medium [35]. In the lens 
fiber cells, the loss of organelles greatly reduces light scattering. Using small 
angle X-Ray scattering, light scattering, and building on concepts used to 
describe transparency in the cornea, it was shown that the cytoplasm in fiber 
cells displays short-range order typically seen in viscous liquids, and can be 
approximated by a model of hard spheres in solution [23, 37].  
 
Figure 1.3: The short-range order of the lens fiber cells maintains transparency. As a 
result of age or disease, the crystallins accumulate damage, which leads to aggregation 
and loss of order. Hence, transparency gets affected [38]. 
 
Over the course of aging or due to disease- and environment-related 
stresses, such as in pathogenic protein aggregation diseases or exposure to 
radiation, the lens crystallins undergo various PTM’s. The alterations in protein 
structure, conformation, and function lead to disruption of the short-range order 
and consequently affects the transparency of the lens (Figure 1.3).  
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Figure 1 | Long-lived proteins and the accu-
mulation of damage. Most proteins undergo a 
constant cycle of synthesis and degradation. 
Some proteins, however, evade degradation and 
are long-lived. Owing to their longevity, these 
long-lived proteins are more prone to the accu-
mulation of damage, which can lead to impaired 
protein function and cellular ageing.
Figure 2 | Crystallin is a long-lived lens protein important for eye function. a | Eye lens structure. 
6JG|RQUKVKQPQHVJGG[GNGPUKUFGRKEVGFKPCETQUUUGEVKQPQHVJGG[GCPFVJGIGPGTCNQTICPK\CVKQPQHVJG
lens structure is sh wn in the inset. The eye lens experiences radial growth, with the older lens fibre cells 
residing in the centre and the younger replicating cells residing on the outer rings. As lens cells differenti-
ate, they degrade their organelles so that older lens fibre cells consist predominantly of ordered crystallin 
arrays. b | As the eye lens ages, long-lived crystallin molecules accumulate damage. This leads to their 
aggregation into larger disordered structures which disrupts their transparent properties and results in 
an opaque lense and impaired vision.
affect cell function (FIG. 1). To illustrate the 
potential impact that a long lifetime has on 
protein function, we first discuss crystal-
lin, a well-studied long-lived protein that is 
confined to eye lens cells and experiences 
age-dependent changes and modifications 
that have physiological consequences that 
are specific for eye lens function. Next, we 
focus on the extracellular matrix (ECM) 
proteins collagen and elastin and, finally, we 
discuss the NPC, a multiprotein assembly 
containing long-lived components that are 
not solely structural in nature, but also have 
an active role in the transport of molecules 
into and out of all nuclei. These are just a 
few examples of long-lived proteins with 
important functions. As these long-lived 
proteins age, their functions decline, which 
may have implications for the ageing of their 
respectiv e cells and tissues.
Crystallin and eye lens structure
Crystallins from the eye lens were among 
the first long-lived proteins to be discov-
ered, and they represent the perhaps most 
complete model, to date, linking protein 
longevity and adverse consequences15. 
Crystallins, which are expressed as three 
different isoforms (α-crystallin, β-crystallin 
and γ-crystallin), comprise >90% of the total 
protein content in eye lens fibre cells and 
>35% of their wet weight20,21. Their longevity 
is derived from the unique developmental 
programme that the lens fibre cells undergo 
during embryogenesis and adult life. The 
bulk of the lens is composed of non-dividing 
lens fibre cells that vary in composition with 
age, with the oldest fibre cells located in the 
centre and cells of decreasing age located 
towards the outer layer22 (FIG. 2a). The outer-
most layer is composed of a replicating 
population of cells that gives rise to the 
underlying fibre cells. Upon differentiation 
into non-dividing fibre lens cells, their orga-
nelles, including the nucleus, are degraded 
through protease- and nuclease-regulated 
processes, and ultimately membrane-
enclosed bags of crystallins are left behind23. 
This organelle evacuation is necessary to 
ensure the transparency of the lens, as orga-
nelles scatter light, whereas ordered proteins 
(crystallins) do not24. This differentiation 
process occurs throughout adult life and 
produces rings of new fibre cells analogous 
to the rings of a tree. As fibre cells have no 
organelles, protein synthesis and protein 
degradation are minimal or non-existent, 
and crystallins and perhaps other proteins 
that were synthesized at the birth of the cell 
persist throughout the life of the organism.
As lens fibre cells lack the ability to main-
tain protein homeostasis through protein 
turnover, other mechanisms must be in place 
to help preserve the proper folded state of 
crystallins. For example, α-crystallin func-
tions as a molecular chaperone, as it binds 
and maintains the folded state of β-crystallins 
and γ-crystallins25,26. Moreover, the absence 
or mutation of α-crystallin accelerates the 
aggregation of lens proteins26,27. A second 
mechanism involves reactive oxygen species 
(ROS) ‘scavengers’ in fibre cells. Compounds 
such as reduced glutathione (GSH) circulate 
from the outer lens epithelium to the lens 
interior, thereby clearing oxygen radicals 
and other oxidizing compounds from fibre 
cells28,29. These systems help prevent the 
misfolding, aggregation and accumulation of 
damaged long-lived crystallins. Nonetheless, 
the activity of crystallins does decrease with 
damage and age30–33.
These quality control mechanisms for 
crystallins are limited and over time cannot 
meet the demand of the increasingly stressed 
lens-cell proteome. Lens crystallins must 
cope with unique stresses such as ultraviolet 
radiation and common ones such as oxida-
tive stress. These insults result in several 
modifications of the lens proteins, including 
deamidation, glycation, mixed disulphide 
bond formation and truncation34–39 (BOX 2). 
In response to damage, crystallins unfold and 
aggregate into large molecular weight spe-
cies as biological repair mechanisms become 
exhausted40,41. These large aggregates are less 
transparent than the natively folded protein, 
resulting in opaque lenses and impaired 
vision, also known as cataracts (FIG. 2b). 
Luckily, modern medicine has devised a way 
to revive these ageing lenses using surgery to 
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1.2 Age-Related Post-Translational Modifications of Human Lens 
Crystallins 
Lens crystallins are characterized by their high degree of conservation 
across species and their long-term stability. There are a number of features that 
promote stability of the crystallins in the mammalian visual system. To start with, 
native crystallins are not prone to be digested by peptidases and proteases. The 
process of N-terminal acetylation seems to protect α and β-crystallins from 
getting cleaved by causing the subunits to become ‘hidden’ within the interior of 
aggregates [13]. The chaperone activity of α-crystallin also prevents precipitation 
of the different crystallin species [13, 15, 39]. 
A key cause of post-translational modifications (PTM) in proteins is 
oxidation, and the lens protects itself by synthesizing a high concentration of the 
antioxidant, glutathione. Over time, the lens is continually exposed to sunlight. 
Photo-oxidative damage to crystallins is primarily reduced by the cornea, and to 
an extent by small-molecular-weight UV filters based on metabolites of the amino 
acid tryptophan. The cornea helps by filtering out the low wavelength, high-
energy, components of light below 300 nm, and the UV filters absorb light in the 
300–400 nm range. In the absence of metabolic activity in the majority of the lens 
tissue, the need for oxygen is very low. Additionally, the protein synthesis that 
occurs in the outer cortex uses up oxygen. Finally, it has been postulated that 
due to the temperature of the anterior of the eye being 2°C lower than body 
temperature, long-term stability of the proteins might be enhanced [13, 30].  
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Despite these protective mechanisms, it has been definitively established 
that lens crystallins undergo extensive PTM’s over the course of aging, resulting 
in gain of some protein forms, loss of others, loss of portions of the soluble 
fraction, and gain in high molecular weight or the insoluble fraction [7, 12, 13, 32]. 
The PTM’s and the ensuing effects are accelerated in the case of protein 
condensation diseases like Alzheimer’s disease, or when exposed to atypical 
conditions like exposure to high concentrations of hydroxyl radicals [18, 40]. 
Reduction in levels of glutathione and UV filters, and an increase in covalently 
bound crystallin-UV filter complexes that can absorb UVA exacerbate age-related 
changes [13, 41].  
Major PTM’s that have been detected over the course of aging are: 
phosphorylation – addition of a phosphate (PO43-) group that can cause 
conformational changes; racemization – conversion of pure enantiomers into a 
mixture of enantiomers with different chirality, which can affect the particles’ 
interactions; deamidation – loss of an amide functional group resulting in loss of 
activity, conformational changes, and degradation; truncation – degradation or 
cleavage into smaller peptide chains; methylation – addition of a methyl group to 
the protein, causing functional and conformational changes; glycation – covalent 
bonding of protein with a sugar molecule, such as fructose or glucose resulting in 
damage to protein functionality; and thiolation – modifications involving sulfhydryl 
groups, which can alter conformation (14). Changes in the protein environment of 
the lens start early: prenatally, there is significant synthesis of γ-crystallins, and 
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soon after birth, most of the γ-crystallins are present as γS type. Mass 
spectrometric analysis, 2D gel electrophoresis, and size exclusion 
chromatography have shown that fetal γ-crystallins comprise of three species: 
γC, γS, and γD. With advancing age, there is an increase in heterogeneity, overall 
loss of all three primary forms, decrease in relative amounts of γC, and increase 
in relative amounts of γS. The modifications associated with these changes 
appear to be deamidation and disulphide bonding based on calculated molecular 
weights of the principal peaks, as well as an increase in acidic forms [14, 32, 33].  
In the first three years after birth, there appears to be significant changes 
in the protein species. New protein forms are seen between the βB1 and βB2 
crystallin subunits, and both acidic and basic species are formed around βA1 
crystallin. There are truncated and deamidated forms of βB1, βA1, and βA3 
formed with age, resulting in decrease of the native versions. A deamidated form 
of βA4 and deamidated and disulphide-linked forms of βB2 were observed in 
older lenses as well. With respect to changes seen in α-crystallins with age, there 
was an increase in acidic forms and as well as in the diversity of protein forms of 
both αA and αB, indicative of increase in heterogeneity. The ratio of the αB:αA 
subunits increased from 1:2 in fetal lenses to 2:3 in adults. Modifications 
associated with α-crystallins have typically been shown to be deamidation, 
disulphide bond formation, isomerization, phosphorylation, and truncation from 
the C-terminal end. The most significant change in the α-crystallin class is the 
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conversion of soluble protein into the insoluble form with advanced age. Studies 
have found that up to 90% of α-crystallins change from the soluble to insoluble 
state, likely as a result of binding to other damaged and unfolded proteins, further 
emphasizing its role as a molecular chaperone [12, 13, 32, 33, 41, 42]. 
As a result of PTM’s the protein homeostasis in the lens gets gradually 
affected and due to lack of protein turnover, damage accumulates. Presence of 
more unfolded or partially folded protein forms, due to PTM’s, invokes α-crystallin 
driven chaperoning events, which in turn causes formation of high-molecular 
weight complexes [43–46]. The scavenging system normally operating in the 
lens, responsible for reducing oxidative stress, is also affected by age-dependent 
modifications leading to further damage to the crystallins [41]. Accumulation of 
aggregates increases stiffness in the lens and ultimately participates in the 
development of presbyopia [15]. Structurally, the PTM’s disrupt the short-range 
cellular order that confers transparency. There is greater association of protein 
complexes with lens fiber membranes, which affects cell-to-cell communication, 
increases mechanical stress, and is instrumental in creating a barrier between 
the nucleus and the outer cortical layers [13, 41]. Transport of molecules, such 
as the antioxidant glutathione is restricted, which in turn makes the inner fiber cell 
layers more susceptible to oxidative damage. The result of protein aggregation 
and degradation of structural order is to increase light scattering in the lens [13, 
17–19, 41, 47].  
With increasing time, the molecular changes linked with protein 
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modifications manifest as opacities in the lens fiber cells, particularly in the 
nucleus, site of the longest-lived proteins [13, 16, 22, 43, 48, 49]. A number of 
methods, such as Slit-Lamp Biomicroscopy [7], Protein Gel Electrophoresis [32, 
45], Transmission Electron Microscopy [17, 41], Optical Coherence Tomography 
[50, 51], Scheimpflug Imaging [52–54], Mass Spectrometric Analysis [33, 55], 
and Quasi-Elastic Light Scattering [19, 52, 56], have been employed to detect 
protein changes that take place in the lens. Understanding the effect of PTM’s 
with age might help in development of a quantitative biomarker of aging, a metric 
that has been under considerable investigation [38, 40, 57, 58]. Ocular 
abnormalities have been linked with different systemic and neurological diseases 
[3, 4, 9, 11]. Moreover, studies have suggested that disease-dependent changes 
in the lens precede the pathogenesis in other tissues and organs [59–62].  Thus, 
studying changes in the lens might foster early detection of molecular changes 
related to age, protein modulating disease states, and environmental toxins. 
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1.3 Pathogenic Protein Aggregation in the Human Lens 
 
One of the perturbations that influence modifications to the cellular protein 
environment is protein-potentiated aggregation. A number of diseases, such as 
sickle cell disease, Alzheimer’s disease (AD), Parkinson’s disease, among 
others, identify with the protein aggregation pathology, and these diseases have 
been referred to as ‘molecular condensation diseases.’ The basic element 
common to all members of this class is the attractive energy of interaction 
between specific biologic molecules, which produces condensation into dense, 
frequently, insoluble plaques [18].  Of these condensation diseases, in this 
thesis, we explore AD-related protein pathology in the human lens. 
Alzheimer’s disease (AD) is the most common neurodegenerative disorder 
and the leading cause of dementia [60, 63, 64]. It is the sixth leading cause of 
death in the United States [65]; in 2010, the number of people with AD globally 
was estimated to be 21–35 million [66]. With increasing human lifespan, the 
prevalence of AD has risen, and is expected to continue [67]. The disease is 
characterized by deposition of the protein amyloid-β (Aβ) in the brain [68, 69]. Aβ 
is generated from the amyloid precursor protein (APP) by sequential cleavage by 
two enzymes: β-secretase and γ-secretase. There are two distinguishable forms 
of AD: early-onset or familial, which is rare, and the more common late-onset or 
‘sporadic’ [64, 68]. Currently, there are no therapies or drugs that have been 
proven to cure AD symptoms, and there is growing consensus that this is a result 
of late-intervention in the pathogenesis of the disease [67]. Concurrently, other 
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than visualization of mature senile plaques in the brain through Positron 
Emission Tomography (PET) with Pittsburg compound B (PiB), there are no 
definite early-diagnostic techniques available [70–72]. The presence of high 
levels of Aβ in 20–40% of cognitively normal individuals aged 60–90 years 
suggests that Aβ deposition precedes cerebral atrophy and cognitive decline [67, 
69, 73]. Furthermore, cognitively normal elderly individuals with high Aβ levels 
show significantly faster rates of grey matter atrophy and memory decline than 
those with low Aβ deposition [67]. There is also evidence pointing to a slow rate 
of Aβ accumulation in late-onset AD [67]. Early diagnosis of AD is critical if this 
devastating disorder has to be curbed. 
The link between AD and ocular abnormalities has been demonstrated in 
a number of studies: Alzheimer pathophysiology contributes to higher rates of 
vision loss in the case of glaucoma [74]; in the human eye, Aβ and APP have 
been detected in the retina and are associated with retinal degeneration [69]; 
neuritic plaques found in AD brain tissue also contain αβ-crystallin, a major 
ocular lens protein [69]; Aβ level in the aqueous humor is elevated in AD patients 
compared to non-AD [62]; Aβ and APP have also been detected in mammalian 
lenses [75]; and αB-crystallin has been shown to co-localize with Aβ in the 
human lens [59]. AD-pathology in the lens manifests in the form of cytoplasmic 
opacities in the supranuclear, or outer cortical, region of the lens (Figure 1.2) 
[59]. These cataracts are biochemically, anatomically, ultrastructurally, and 
phenotypically different from age-related cataracts [59], and were not found in the 
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lenses of control subjects. The presence of Aβ in the supranuclear cataracts in 
AD lenses was confirmed using immunohistochemistry, immunoblotting, and 
mass spectrometric analysis [59]. Due to their localization in the peripheral 
cortex, the opacities are often hidden from view by the iris, thus preventing 
detection during regular eye examinations. In a longitudinal study of 1249 
individuals, AD-related lens abnormalities were reported to precede 
neuropathology [60]. Early-detection of AD-related amyloid-β deposition, before 
development into mature plaques in the brain, becomes more important due to 
the increased toxicity of smaller aggregates of Aβ [76–78]. Soluble pre-fibrillar Aβ 
assemblies have been shown to cause disruption of cellular metabolism, 
synapse structure and function deregulation, membrane damage, ionic 
imbalance, oxidative stress, and other cytotoxic effects [79–85]. The fact that AD 
is a protein-condensation disease, influenced by PTM as well as conditions that 
promote PTM’s, lends significance to probing the lens for early signs of AD-
related protein changes [18, 86]. Moreover, the lens is optically accessible and 
preserves changes to the protein environment as a result of lack of protein 
turnover. 
The pathology seen in AD has also been observed in Down syndrome 
(DS), the leading genetic cause of intellectual disability and affecting 
approximately 1 in 700–1000 live births [61, 87]. The presence of Aβ was 
detected in DS brains in the form of plaques [70, 71, 87–89], and in DS lenses as 
supranuclear cataracts [61]. DS is defined by the triplication of chromosome 21, 
  
18 
and the APP gene resides on chromosome 21. Hence, there is an extra copy of 
APP in DS, which results in overexpression of APP’s cleavage product, Aβ. An 
increase in Aβ leads to accumulation as plaques in the brain and as supranuclear 
opacities in the lens of the eye of DS individuals [61]. There is also evidence of a 
high level of soluble Aβ in DS brains from a very early age without the presence 
of mature plaques. Thus, the formation of large cerebral aggregates in DS 
appears to be an end stage product of protein changes that commence early in 
life. Similar to the precedence of lens changes over neuropathology in AD, it has 
been hypothesized that alteration in the lens protein environment might precede 
cerebral plaque formation in DS [61]. Presently, PET-PiB imaging has been 
successful in discerning amyloid-β deposition in DS brains compared with 
controls only late in the third decade of life [70, 71]. While amyloid-β-related 
protein changes are shared between AD and DS, the progression of disease-
related effects is different. DS can be thought of as an early-onset model of AD 
with a 100% correlation in observed pathology. It offers a model where the 
progress of Alzheimer’s-related changes can be followed. This is particularly 
beneficial because heritable early-onset Alzheimer’s disease is relatively rare, 
and due to a lack of effective diagnosis methods, detection of AD pathology isn’t 
possible until late in the disease state.  
A number of techniques have been applied to assess protein changes in 
the lens. In vitro methods have ranged from different spectroscopic analyses [16, 
49], column gel filtration [12, 90], sedimentation equilibrium techniques [29], and 
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electron microscopy [17, 41, 47] to protein gel electrophoresis, mass 
spectrometry and x-ray and light scattering [23, 32, 33, 55, 91, 92], among 
others. In vivo, efforts have mostly focused on imaging methodologies like slit-
lamp biomicroscopy [7], optical coherence tomography [50, 51] and Scheimpflug 
imaging [52–54]. While the in vivo imaging methods have provided valuable 
information to the field, their application as a diagnostic is limited by their 
resolution, which is on the order of microns. Moreover, the outputs from imaging 
approaches do not provide information on the dynamics of the system, such as 
diffusivity of particles. As a result, early-stage protein events cannot be evaluated 
effectively. The technique of quasi-elastic light scattering (QLS) offers a non-
invasive, sensitive, and quantitative method for assessing protein changes [93–
97]. QLS can provide information about particle sizes on the nanometer scale 
and can be used to probe protein-protein interactions and changes in 
conformation of proteins [93, 95, 98]. QLS measures the temporal autocorrelation 
of fluctuations in scattered light intensity. The next section reviews the application 
of QLS for in vivo analysis of modifications in the lens protein environment and 
Chapter 2 discusses the theory underlying the technique. 
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1.4 Review: In Vivo Application of Quasi-Elastic Light Scattering in the 
Lens 
 
One of the first in vivo studies that utilized quasi-elastic light scattering to 
measure protein diffusivity was conducted in rabbit lenses by Tanaka and 
Ishimoto in 1977 [99]. The method of cumulants [100] was applied for 
computation of the average diffusivity from the measured autocorrelation function 
of scattered light intensity. The values obtained in vivo and ex vivo were similar 
and this study showed the ability of QLS to be used in vivo. This work was 
followed by the study of cataract formation [101], and the effects of radiation 
[102] and aging [103] in rabbit lenses in vivo using QLS. Results from these 
experiments corroborated well with in vitro observations, namely: in the normal 
lens, protein motion was slower in the center compared to the periphery; at a 
fixed position, in the normal lens, protein motion was slowed with age; and 
irradiation produced protein changes that preceded observable opacities. 
Initial studies of application of QLS in vivo in humans focused on using 
diabetic patients as a short-term model of cataract development. Changes in light 
scattering signal with an increase in age and diabetes was demonstrated in a 
cohort of 38 diabetic and 19 age-matched non-diabetic subjects [104]. Cumulant 
analysis was used to extract the average diffusivity of lens proteins for each 
subject. The next significant study, done in 1989, also looked at the effect of 
diabetes and age in the human lens [105, 106]. QLS measurements were 
obtained from the lens nucleus of 393 diabetic subjects and 38 non-diabetic 
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subjects. Results confirmed previous epidemiological studies that diabetes 
produced significantly early onset of cataracts compared to control. Extraction of 
the diffusion coefficient was performed using the method of cumulants. Due to 
limitations in design of the digital correlator, different sample times were used to 
try and obtain decay rates for different sized proteins in the measurements. This 
study assumed a bimodal distribution of proteins in the human lens, and the 
choice of sample time was a factor that could have affected the results.  
In 1997, Thurston et al. published on the use of QLS to determine 
contributions of molecular scattering elements to the increase with age in the 
light scattered from the human ocular lens in vivo [56]. This study included 225 
participants between ages 17 and 63. Size distribution analysis was done using a 
double exponential model, with a heuristic assumption of 3 scattering 
components: a fast diffusing, unaggregated protein fraction, slowly diffusing 
protein aggregates, and a very slowly diffusing, relatively immobile component. 
The results demonstrated increase in scattering intensity and correlation time 
with age and proposed that this was due to the pool of fast diffusing components 
transitioning into larger oligomers. A useful metric from this work was a threshold 
for nuclear opacity, determined by comparing results with the Framingham eye 
study and the Chesapeake Bay watermen study, which suggests that about a 
factor of 7 increase in light scattering efficiency from that of the newborn lens is 
necessary to reach a Stage 1 threshold for nuclear opacity. The following year, 
Dierks et al. conducted a clinical study using QLS on a sample set of 79 subjects 
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with ages varying from 9 to 85 years [107]. The study also involved testing 
bovine lens fractions in vitro. Constrained regularization of the inverse Laplace 
transform (CONTIN) [108, 109] was the method of choice in extraction of the 
diffusion coefficient distribution from the ACF’s. Results indicated presence of 
two peaks in the underlying distribution, a fast diffusing component and a slow 
diffusing larger sized fraction. With age, the fast smaller peak got diminished, 
suggesting formation of higher molecular weight species. 
In an effort to characterize the cataractous state of the living lens by a 
single parameter, QLS was used in vivo on a cohort of 66 volunteers aged 
between 10–85 years [110]. CONTIN was applied to compute diffusion 
coefficients and size distributions from the QLS data. The mean value of the 
normalized number weighted distribution was used as the Cataract Index (CI) 
parameter to quantify changes in the lens over age. This index does not reflect 
relative contributions to the signal from particles of different sizes; rather, it’s an 
approximation of the number of particles in the distribution at discrete sizes. 
Two other studies published in 2002 [111, 112] and 2008 [112] by the 
same group and utilizing the same instrument demonstrated the application of 
QLS for clinical assessment of lens protein changes. The device consisted of a 
fiber-optic probe mounted on a corneal topography unit, and the size distribution 
analysis was conducted using the exponential sampling algorithm. The first study 
cohort consisted of 12 human subjects, while the second study examined age-
dependent changes in a cohort of 235 subjects. Results of these studies were 
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interpreted as age-related changes in the relative proportions of α-crystallins. 
Through the discussion presented in this section, we note the ability of 
QLS to be used in vivo for detection of protein changes in the aging lens. When 
analyzing these results, several caveats need to be considered. The differences 
in the various published works are in the specific application, instrumentation, 
sample size, post-acquisition data analysis, and interpretation of findings. Early 
research in this field used QLS to detect differences in diabetic lenses compared 
with control, and some subsequent studies focused on detection of cataracts or 
pre-cataractous changes. Variations in instrumentation have ranged from using 
fiber-optic probes coupled with an imaging system to modified slit-lamp 
ophthalmoscopes. A limitation of using a fiber-optic probe is the need for 
performing an initial scan for every subject to determine the desired 
measurement location. Additionally, in a fiber-optic setup, eye movements cannot 
be tracked, which might add variability in measurement location. Some other 
factors dependent on instrument design that need to considered due to their 
influence on data collection are the scattering volume and scattering angle. The 
extraction of size distributions from QLS autocorrelation functions is a complex 
problem, and various algorithms have been used in literature. Chapter 5 in this 
thesis discusses features and limitations of four such size distribution algorithms. 
A common limitation in a large number of QLS studies is the inability of some 
widely utilized algorithms to compute particle size distributions from complex, 
polydisperse protein environments, such as found in the lens fiber cells. 
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1.5 Thesis Overview 
Long-lived lens crystallin proteins undergo age-dependent changes over 
the human lifespan. These modifications are amplified as a result of pathological 
protein interactions characteristic of certain diseases, such as Alzheimer’s 
disease, as well as upon exposure to perturbations (e.g. radiation, oxidative 
stress, metals). The lens offers an ideal system to study molecular aging 
because of its optical accessibility, transparency, age-dependent spatial order 
and absence of protein turnover in the lens fiber cells. The protein changes in the 
lens can be detected using the technique of quasi-elastic light scattering (QLS). 
The overarching hypothesis of this thesis work is that assessment of lens protein 
changes by the application of QLS affords potential as a quantitative biomarker 
of molecular aging. 
The following chapter discusses the theory related to QLS and the 
mathematical extraction of size distributions from autocorrelation functions, 
methods used in in vitro experiments, and details of the in vivo clinical studies. 
Chapter 3 presents the results obtained from long-term in vitro studies on the 
changes in human lens proteins upon exposure to physiologically relevant 
perturbation. In Chapter 4, we apply QLS in vivo in three clinical studies to 
observe age-dependent and AD-related molecular changes in the lens. A 
comparison of various algorithms used for the extraction of size distributions from 
light scattering data is the subject of Chapter 5. This thesis concludes with a 
discussion about major findings, implications, and future work. 
  
25 
Chapter 2 
Experimental Methods and Techniques 
2.1 Quasi-Elastic Light Scattering 
 
2.1.1 Theory 
 
Light is a form of electromagnetic radiation that propagates as waves in 
which the oscillating electric and magnetic fields, and direction of propagation are 
all mutually perpendicular [113]. If any particle in space is subjected to an electric 
field of strength E, the particle’s constituent electrons become subject to a force 
in one direction and its constituent nuclei to a force in the opposite direction, 
which produces a dipole moment. For particles much smaller than the 
wavelength of light, the electric field at each point of the particle, at any instant, 
will be identical. As a consequence of the incident light beam, an oscillating 
dipole is induced in the particle. An oscillating dipole is itself a source of 
electromagnetic radiation, and it is this secondary radiation that constitutes the 
scattered light measured using QLS [114].  
The scattered radiation propagates as a spherical wave, extending in all 
directions, but the field strength depends on the direction. The frequency of 
scattered light is the same as that of the incident light. Rayleigh theory can be 
used to describe intensity of scattered light for a particle much smaller than the 
wavelength of incident light [113,114]. The amplitude of the scattered wave 
depends on the mass of the scattering particle, refractive index, scattering angle, 
and wavelength and direction of polarization of the incident light. According to 
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Rayleigh theory, the intensity of light scattered by one particle is inversely 
proportional to the fourth power of the wavelength of light (I∝λ-4) and directly 
proportional to the sixth power of its radius (I∝r6) [113]. The phase of the 
scattered wave depends on the position of the scattering particle and can be 
described in terms of the scattering vector q (Figure 2.1). Relative to the phase of 
a wave scattered at the origin, the phase of a wave scattered at a point with 
radius vector r is ‘q.r’. The length of the scattering vector is: 𝑞 =   4𝜋 𝜆   sin(Θ 2)    (2.1) 
θ is the scattering angle and λ is the light wavelength in the scattering medium,   
λ = λo/n, where n is the refractive index of the medium and λo is the wavelength 
of the incident light in vacuum. 
 
 
Figure 2.1: The scattering vector q describes the difference in path between the unit 
vector e1 along the direction of the incident light and the unit vector e2 along the direction 
of the scattered light. The position of the scattering particle is given by the vector r [96]. 
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wave scattered at the origin, r = 0. The intensity I of the scattered light per unit
area is proportional to the square of the amplitude of the electromagnetic field,
that is
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= #
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2.1.2. Intensity of Scattering by a Small Particle
Consider an aggregate composed of m monomers, each producing scattered
electromagnetic wave E
0
. Let the aggregate center of mass be at point R. If the
size of the aggregate is small, so that q . (r
k
 – R) <<1 for all monomers, Eq. 1
reduces to E % mE
0
 exp(iq . R + i&). Thus the intensity of the light scattered by
the aggregate is proportional to the aggregation number squared, I = m
2
I
0
,
where I
0
 is the intensity of scattering by a monomer. The quadratic depen-
dency of scattering intensity on the mass of the scatterer is the basis for optical
determination of the molecular weight of macromolecules (9), for various tur-
bidimetry and nephelometry techniques, and for understanding many natural
phenomena, from appearance of clouds to cataractogenesis in the eye lens (10).
Fig. 1. The scattering vector q. The path traveled by a wave scattered at the point
with radius vector r differs from the path passing through the reference point O by two
segments, 1 and 2, with lengths l
1
 and l
2
, respectively. The phase difference is '( = 2)
(l
1
 + l
2
) / *. The segment l
1
 is a projection of r on a unit vector e
1
 in the direction of the
incident beam, i.e., l
1
 = r . e
1
. Similarly, l
2
 = r . e
2
, where e
2
 is a unit vector in the direc-
tion of scattering. Thus '( = (2)"/ *)(e
1
 – e
2
) . r. The vector q = (2) / *)(e
1
 – e
2
) is
called the scattering vector.
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When more than one molecule is responsible for the light scattering, the 
scattered light intensity can be obtained by first calculating the scattered electric 
field for each scatterer, summing the fields, and then squaring the result 
(Equation 2.2). 𝐼   ∝ 𝐸! = | 𝐸!𝑒!𝒒.𝒓𝒌|!!     (2.2) 
Ek is the amplitude of the wave scattered by the kth particle located at position rk. 
In the case of a small cluster of particles with the center of mass at point R, 
q. (rk – R) << 1 for all monomers, and Equation 2.2 can then be expressed as: 𝐼 =   𝑚!𝐼!         (2.3) 
where m is the number of monomers and Io is the intensity of scattering by a 
monomer. 
A typical scattering experiment involves collection of light from many 
particles at random locations rk within the scattering volume. The phases of the 
various components of the electric field are changing with time because the 
particles undergo Brownian motion. At any point in time, the phases of the 
particles in the observational volume will add either constructively or 
destructively. As a result of random orientations of the particles, the observed 
phase values at any position and time point is random as well. Thus, the time-
averaged dependence of scattered intensity on phase becomes zero and 
averaged scattering intensity is described by Equation 2.4, where N is the 
number of individual particles and Is is the intensity scattered by one particle. < 𝐼! >=   𝑁𝐼!(1)     (2.4) 
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The instantaneous value, however, at the point of observation, fluctuates around 
its average value due to the random fluctuations in phase. Quasi-elastic or 
dynamic light scattering (QLS, DLS), in essence, measures the temporal 
correlations in the fluctuations in the scattered light intensity. Typically, a laser is 
used in a QLS setup as the incident light source. While the source can, in theory, 
be other conventional light sources, there are significant advantages to using a 
monochromatic and coherent source of light such as a laser. When light is 
focused to a small region in the sample, the monochromatic sources provides a 
much higher intensity, which in turn affects the intensity of scattered light. A 
source with low spatial or temporal coherence would have intrinsic fluctuations, 
which could adversely impact scattering from the particles under observation. 
The pattern of fluctuations in scattered light intensity from the particles in 
the medium, called an interference pattern or ‘speckles,’ is determined by the 
positions of the scattering particles. The time required for the fluctuations to take 
place is the most important characteristic of the signal as that time contains 
information about the dynamic properties of the scatterer. The translation 
diffusion constant (D) can be obtained from these measurements using the 
Stokes-Einstein formula (Equation 2.5), which for a spherical molecule, is related 
to the radius (r). 𝐷 =    !!!!!"#      (2.5) 
Here, kB is the Boltzmann’s constant, T the absolute temperature, and η the 
viscosity. Thus, a large molecule will have a smaller diffusion coefficient and vice 
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versa. The fluctuations in the intensity of scattered light are registered by a 
photodetector. The detection of the photons constitutes a random process, and 
information is contained only in the temporal correlations in this signal. For a 
monodispersed sample of spherical particles in an aqueous medium, the electric 
field correlation function is described as in Equation 2.6. 𝑔 ! 𝜏 =   𝑒!!!!!    (2.6) 
D is the diffusion coefficient as described above, q is the scattering vector, and τ 
is the delay or correlation time. When the scattering system is polydisperse, 
where particles of different shape or size are present in the solution, Equation 2.6 
is generalized to: 𝑔 ! 𝜏 =    𝐼!  ! 𝑒!!!!!!      (2.7) 
In Equation 2.7, summation is done over all k scattering components in the 
sample. In an experimental setting, the signal received by the photodetector is 
correlated over time by a correlator to produce the autocorrelation function of the 
intensity, I(t) (Equation 2.8), also known as the second order correlation function. 
The angular brackets denote an averaging over time.  𝐺! 𝜏 =  < 𝐼 𝑡   𝐼 𝑡 + 𝜏 >  (2.8) 
The second order correlation function is related to the first order or electric field 
correlation function (Equation 2.9) through the Seigert relationship (Equation 
2.10). This relationship is applied for Gaussian random processes, which is 
typically the nature of scattered light. 𝐺! 𝜏 =  < 𝐸 𝑡 𝐸∗ 𝑡 + 𝜏 >   (2.9) 
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𝐺! 𝜏 =    𝐼!!  (1+   𝛾𝑔! 𝜏 !)             (2.10) 
Io is the average intensity of the detected light and γ is an efficiency factor that is 
instrument dependent. For instance, collection from a small area makes γ ≈ 1, 
while the effect of sampling from a large area averages out intensity fluctuations 
and γ << 1. Other factors that affect γ are laser beam stability and beam diameter. 
The temporal correlation of the fluctuations in scattered light intensity is 
efficiently computed with the use of a digital correlator. A correlator is a signal 
comparator and allows for measurement of the degree of correlation between 
two signals (cross-correlation) or between a signal and its delayed version 
(autocorrelation). When a signal is compared with itself at time zero, then the two 
signals will be perfectly correlated. However, with time, in a process such as light 
scattering, the signal changes and thus the correlation decreases. For a truly 
random signal, the correlation will eventually decay to zero when the observed 
signal bears no relationship with the original. For a monodisperse sample, the 
decaying correlation function can be expressed as Equation 2.6, and for 
polydisperse samples, by Equation 2.7 [96]. 
The fundamental operations of a digital correlator are:  
1) Counting of the photons over sampling time intervals of width δt 
2) Delaying these samples for some integer multiple of δt, the lag time τ = kδt 
3) Multiplying the delayed and original data samples  
4) Summing these products  
Steps 3 and 4 are operations performed for many different delay or lag times in 
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parallel. A corresponding number of channels are used to store the results of 
these computations. The acquisition time of detection should be large relative to 
the sample decay time (in the order of ms, s, or more).  
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2.1.2 Experimental Setup 
 
As described in the preceding section, QLS has the ability to measure the 
intensity temporal correlation of light scattered by particles much smaller than the 
wavelength of light. This permits detection of changes in particle sizes with 
nanometer resolution. QLS can be applied in vitro and in vivo. These features 
make QLS an efficient tool for detection and quantification of early changes in the 
molecular environment where other techniques, such as Slit-Lamp 
Biomicroscopy, Optical Coherence Tomography (OCT), and Scheimpflug 
Imaging, cannot detect changes. Comparison of QLS with these imaging 
techniques is discussed in more detail in Chapter 1 – Section 3, and in Chapter 4 
– Section 2 in context with results obtained from in vivo studies. 
A schematic for the QLS devices used for obtaining the data discussed in 
Chapters 3–5 is presented in Figure 2.2. It is composed of two linearly polarized, 
low-intensity, near-infrared laser diodes (λ = 780 nm, power P = 0.3 mW). The 
optical beam from Laser 1 passes through a beam splitter (BS) and is focused in 
the sample of interest (a glass cuvette in in vitro experiments or the human lens 
in a clinical setting). Backscattered light is collected at a fixed angle between the 
incident beam and the detection path by a lens doublet and an image is formed 
on the pinhole mirror. A piezo mirror, in conjunction with a CCD-driven tracking 
system maintains the acquisition location (compensates for the voluntary eye 
movement). A small portion of light passes through the pinhole and is delivered 
by an optical fiber to a single-photon avalanche photodiode (Perkin Elmer – 
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C30902SH/DTC). Autocorrelation functions are recorded by multi-tau real time 
digital correlator (Flex99OEM-480). Laser 2 is only used during the pre-alignment 
procedure to help the instrument operator locate the desired location in the 
human eye. In conjunction with the cylindrical lens (CL), Laser 2 forms an optical 
slit similar to a traditionally used slit-lamp ophthalmoscope. Laser 2 is turned off 
during data acquisition. In order to reduce power deposition in the sample/human 
eye, the two lasers are never active concurrently. Moreover, the laser beams 
diverge significantly before reaching the retina and laser power density is well 
below maximum permissible exposure (MPE) level and within the American 
National Standards Institute Guidelines for the Safe Use of Lasers. 
 
 
 
Figure 2.2: Instrument Setup – optical diagram of QLS instrument. CL – Cylindrical Lens; 
BS – Beam Splitter; GL – Grin Lens 
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Data collection for in vivo and in vitro studies was performed using two 
different QLS instruments, with the same general construction as described in 
Figure 2.2. There are two major differences between the in vitro and the in vivo 
QLS setups. The angle between the incident laser beam and the collection path 
for the in vitro device was 120°, while for the in vivo was 90°. 
Refraction of the incident beam occurs at the interface with the sample 
(cuvette or human eye) (Figure 2.2) due to the refractive index mismatch 
between air and sample medium. As a result of the refraction at the sample’s 
surface, the true angle of scattering within the sample is different from the 
apparent angle between the source and collection path. The true angle would 
also depend on the sample used, e.g. dimensions of the cuvette. Using known 
sizes of polystyrene beads, the true scattering angles were calculated to be 
140.5° for the in vitro device and 110.6° for the in vivo device. 
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2.1.3 QLS Data Filtering 
 
For in vivo measurements, autocorrelation functions (ACFs) acquired 
whilst the subject was moving and the eye was in a non-ideal location (visually 
determined from the CCD images captured prior to data acquisition) were 
rejected. Following this step, the subsequent rejection filters were common to in 
vitro and in vivo data. All remaining data replicates for a given subject (sample) 
are pooled together. ACF’s with amplitude > 2 are further rejected. This is 
because, in theory, for Gaussian chaotic light, the amplitude of the second order 
intensity correlation function cannot be > 2. The ACF of scattered light intensity is 
described as a decaying exponential; hence, the ACF’s that are not 
monotonically decreasing are removed from further analysis. The amplitude for 
each remaining replicate is compared against the mean amplitude, and 
measurements with values >2σ from the mean are culled. In a normal 
distribution, 2σ represents 95.45% of the data, and rejection of values outside 
this range was used as a statistical parameter to exclude outliers. Analysis with 
different σ rejection criteria might be interesting to test in future studies. 
Replicates with correlation time values greater or less than the mean correlation 
time by 100% are removed. This was an empirically determined cutoff factor to 
ensure that a few highly variant values would not bias the mean. Out of the 
remaining ACF’s, those with correlation times varying >2σ from the mean are 
rejected. Finally, those replicates with time averaged intensity varying >2σ from 
the mean are removed. 
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2.1.4   Instrument Validation 
Operational validation and instrument testing was performed using 
polystyrene bead suspensions. In theory, a linear increase in concentration of 
particles of a known size should result in a linear increase in scattering intensity. 
This relationship was tested and confirmed using beads of radius 50 nm (Figure 
2.3). Correlation time is also linearly dependent on particle size based on theory. 
Using different known sizes of beads, this correlation was examined and 
confirmed (Figure 2.4).  
 
 
 
Figure 2.3: Scattering intensity of light increases linearly with concentration of 50 nm 
polystyrene beads. Error bars represent standard deviation of the mean. R2 = 1.00 for 
the linear fit. 
50nm beads 
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Figure 2.4: Correlation time increases linearly with polystyrene bead radius. Error bars 
represent standard deviation of the mean. R2 = 0.99 for the linear fit. 
 
 
An example of an autocorrelation function acquired from a monodisperse 
suspension of 50 nm radius beads is shown in Figure 2.5. From an 
autocorrelation function, the particle size distribution can be extracted using a 
number of different mathematical techniques. A comparison of these techniques 
is discussed in Chapter 5. All size distributions extracted from data presented in 
the remainder of this thesis utilized the Non-Negative Truncated Singular Value 
Decomposition (NTSVD) algorithm available in the DYNALS [115] software 
package. The rationale behind the choice of using DYNALS versus other 
techniques is also discussed in Chapter 5. A high degree of repeatability and 
accuracy in size distribution extraction was obtained using multiple sets of data 
from a 50 nm radius bead suspension (Figure 2.6). The empirically calculated 
mean bead radius for the three data sets was 48.3 nm.  
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These results validated the operational efficiency of our QLS device and 
determined that the algorithm used for size distribution analysis produced 
repeatable and accurate data. 
 
Figure 2.5: Autocorrelation function acquired from a suspension of 50 nm radius beads 
 
 
 
 
Figure 2.6: Size distributions extracted from ACF’s of 50 nm radius polystyrene beads. 
Scans 1,2,3 represent three separate sets of measurements each with 15 replicates and 
acquisition time for each replicate = 10 s. Empirically calculated mean = 48.3 nm. 
50nm beads 
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2.2 Particle Size Extraction from Quasi-Elastic Light Scattering Data 
 
Quasi-elastic light scattering is characterized by scattering of incident light 
by particles much smaller than the wavelength of the source. The random motion 
of the particles in the medium gives rise to fluctuations in the scattering intensity. 
When the fluctuations are correlated at successive time intervals, an 
autocorrelation function (ACF) is generated. The dynamics of the scattering 
system, namely the diffusion coefficient distribution, are contained within the 
ACF. Consequently, the general objective of analyzing QLS data is to compute 
the diffusion coefficient(s) from Equation 2.7, which can be expressed for a 
continuous distribution of scattering particles as: 𝑔! 𝜏 =   1 𝐼! 𝐼 𝐷   𝑒!!!!!  𝑑𝐷   (2.11) 
  
where I(D)dD = N(D)I0(D)dD is the intensity of light scattered by particles having 
their diffusion coefficient in interval [D, D + dD], N(D)dD is the number of these 
particles in the scattering volume, and I0(D) is the intensity of light scattered by 
each of them. In order to calculate the diffusion coefficient(s) of the scatterer(s), 
the intensity distribution I(D) or the number distribution N(D) needs to be 
reconstructed from the measured intensity ACF. 
The kind of relationship expressed in Equation 2.11 is called a “Fredholm 
integral Equation of the first kind” and its solution is known to be an “ill-posed 
problem” [115]. A problem is termed “ill-posed” when there are significantly 
different distributions I(D) that lead to nearly identical correlation functions of the 
scattered light and therefore are equally acceptable fits to the experimental data. 
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There are a number of algorithms that have been developed to find the optimal 
approximation, and a detailed comparison is performed in Chapter 5.  
In this thesis, the method that was chosen to extract size distributions is 
the Non-Negative Truncated Singular Value Decomposition (NTSVD) algorithm, 
part of the DYNALS software package. This algorithm was selected based on 
initial tests on known samples of polystyrene beads, information presented in the 
associated technical paper discussing the algorithm’s capabilities, and the ease 
of use of the software interface. The NTSVD algorithm is related to eigenvalue 
decomposition. It allows the solution matrix X to be diagonalized using a matrix 
composed of singular values, which are the square roots of the positive 
eigenvalues of X. Further details are provided in Chapter 5. For both in vitro and 
in vivo data, the following parameters were used for size extraction: 
a) Correlator channel range – analysis was performed on data contained 
within channels 20–110 of the correlator. This corresponded with lag times 
of ~0.01 – 27.5 ms. Restriction to this range helped eliminate artifacts due 
to noise in the shorter delay time channels, while still ensuring that sample 
dynamics were not lost. 
b) Fitting boundaries – DYNALS allows for the setting of ‘Auto Boundaries’, 
which is the maximum possible range (9.6e-5 – 3.3e8 ms) the algorithm 
uses for producing a solution. A broad fitting range allows for computation 
of a wide range of diffusion coefficients/ particle sizes (if present in the 
sample).  
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c) Fitting method – multi-pass algorithm was used. This processes the 
second order correlation function. The single-pass algorithm is also 
available and works with the first order correlation function, but is noted to 
be less stable than the multi-pass. 
d) Number of intervals – the number of intervals used to discretize the 
distribution range was 200 (the maximum). Having a large number of 
intervals helps in improving resolution of the solution.  
 
The other physical parameters required for size distribution analysis 
related to experimental conditions were wavelength, scattering angle, 
temperature, refraction index, and viscosity. For in vitro experiments, the 
scattering angle used was 140.5° (discussed in QLS setup - see section 2.1), 
temperature was 293K (samples were equilibrated to room temperature before 
measurements), refractive index of 1.33 (corresponding to water at 20°C), and 
viscosity of 1 cP (corresponding to water at 20°C). The parameters used in vivo 
were: scattering angle – 110.6°, temperature – 310K (measurements were done 
in the lens of the eye), refractive index – 1.4 (mean refractive index of the lens), 
viscosity – 5.74 cP [116]. The wavelength for both in vitro and in vitro 
measurements was 780 nm. 
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2.3 Analysis of Human Lens Proteins 
 
2.3.1 Extraction 
 
Posthumous human eyes were received fresh and the lens was then 
dissected and frozen and kept at -80°C until any experiment. Individual lenses 
were homogenized in a 2 ml Wheaton tissue grinder using 0.8 – 1 ml of purified 
water (Millipore Milli-Q purification system). The homogenized tissue was 
centrifuged at 100,000 g’s for 60 min at 4°C in a Beckman Optima TL-100. The 
supernatant, which constituted the water-soluble fraction, was used for the in 
vitro experiments. Concentration of the extracted water-soluble fraction ranged 
from 25–35 mg/ml depending on the lens. Samples were diluted appropriately in 
phosphate buffered saline (PBS) (no Ca2+, no Mg2+) and incubated at 37°C. The 
concentration used for assessing time-dependent changes (Chapter 3 – Section 
1) was 1 mg/ml. The Bicinchoninic Acid Assay (BCA) (Pierce) was used to 
determined protein concentrations. 
 
2.3.2 Exposure to X-Ray Radiation  
 
In order to study the effect of X-ray radiation on changes in water-soluble 
lens proteins, samples diluted to 1 mg/ml in PBS (no Ca2+, no Mg2+) were 
exposed to a single dose of 340 Gy using the X-RAD 320 (Precision X-Ray Inc.) 
The dose was administered within 30 min, a duration value that was initially 
tested to ensure heating was not a factor. The choice of the radiation dose was 
based on the highest output possible within 30 min from the X-RAD 320, while 
still being in the range used in previous studies [117–120]. After being irradiated, 
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the protein samples were incubated at 37°C and monitored over time using QLS 
(Chapter 3 – Section 2). 
  
2.3.3 Oxidation of Lens Proteins 
Water-soluble human lens proteins were diluted to 2.5 mg/ml in PBS (no 
Ca2+, no Mg2+). An oxidation protocol based on the Fenton reaction was used 
[121]. FeCl3.6H2O and ethylene-diaminetetra-acetic acid (EDTA) were dissolved 
together in 150 mM NaCl (phosphate free) at concentrations of 1 mM and 3 mM 
respectively. This stock solution was then added to the protein at 1:10 to result in 
final concentration in the reaction mixture of 0.1 mM iron and 0.3 mM EDTA. 1 
mM 30% H2O2 was added to the reaction mixture to start the oxidation process. 
QLS along with Protein Gel Electrophoresis (see section 2.4 below) and 
Transmission Electron Microscopy (see Section 2.5 below) were used to detect 
oxidative-damage to the proteins (Chapter 3 – Section 4). 
 
2.3.4 Exposure to Zn2+ 
The effect of Zn2+ on water-soluble human lens proteins was tested by 
incubating protein samples diluted to 1 mg/ml in PBS (no Ca2+, no Mg2+) with 16 
µM of Zn2+. The divalent zinc was introduced to in the form of Zn-Histidine at a 
stock concentration of 1 mM in water. The human lens proteins + Zn2+ samples 
were stored at 37°C and monitored over time using QLS (Chapter 3 – Section 5). 
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2.3.5 Incubation with Human Amyloid-β40 (Aβ40) 
 
Synthetic human Aβ40 was acquired from the Keck Laboratories (New 
Haven, CT). A number of solubilization protocols were tested in order to address 
the difficulty in obtaining a relatively monomeric solution at the onset of any 
experiment. The protocol that was adopted for QLS measurements was based 
on a previous report and communication with the authors [122]. Human Aβ40 was 
first lyophilized in 1% NH4OH solution and the lyophilized product was stored at -
20°C until the experiment. Dissolving lyophilized Aβ (pH ~2–3) in neutral pH 
buffers causes the solution to pass through the isoelectric point of Aβ (pI = 5.5). 
At this pH, aggregation is maximal and solubilization is minimal. Hence, an initial 
step of treatment with an alkali buffer prevents the reaction to pass through the 
isoelectric point of Aβ. 1mM NaOH was used to dissolve the lyophilized Aβ40 to a 
concentration of ~1 mg/ml and the peptide samples were sonicated for 2 minutes 
in a Misonix Q700 sonicator. The Aβ40 was then diluted in a zinc-free buffer to 
required concentrations and the pH adjusted to 7.3. PBS (no Ca2+, no Mg2+) was 
used. These samples were filtered using 0.2 µm Anatope filters in an 
ultracentrifuge. The supernatant was used immediately for Aβ40 aggregation 
experiments as well as for incubation with the water-soluble fraction of human 
lens proteins. For the experiments discussed in Chapter 3 – section 7, 65 µM of 
human Aβ40 in PBS (no Ca2+, no Mg2+) was incubated with 2.5 mg/ml of lens 
proteins. The choice for hAβ40 concentration was based on previous research 
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[173–175] as well as on results of pilot experiments that examined time-
dependent aggregation of hAβ40 in solution. Using the aforementioned protocol, 
the maximum concentration that could be consistently obtained post-filtering was 
approximately 80 µM. Concentrations beyond this value resulted in accumulation 
of the protein on the filter membrane as a result of aggregation reactions with 
rapid rate kinetics. In our range-finding experiments, we also determined that the 
lowest concentration that produced changes in QLS signal in vitro was 
approximately 40 µM. 
 
 
2.4 Protein Gel Electrophoresis 
One-dimensional sodium dodecyl sulfate (SDS) protein gel 
electrophoresis was performed according to the NuPAGE Novex protocol  (Life 
Technologies). Water-soluble human lens crystallins were run at neutral pH (7.0) 
on 4–12% Bis-Tris gels under denaturing but non-reducing conditions. No 
reducing agent was used in order to avoid breaking up of protein subunits. Lens 
crystallin samples were run at 10 µg per lane. Staining of the gels were 
performed using the Colloidal Blue Staining protocol (Life Technologies). 
 
 
2.5 Transmission Electron Microscopy 
 
Negative stain Transmission Electron Microscopy (TEM) was performed 
on lens crystallin samples using the JEOL 1200EX - 80 kV. The protein samples 
were spotted on 150-mesh grids, coated with a film of copper, at a concentration 
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of 0.1 mg/ml. The process involved placing the grids on 12 µL droplets of the 
sample for 60 s. The grids were washed twice by placing them on 12 µL of water 
droplets for 30 s each. Finally, the grids were stained by placing them on 10 µL 
droplets of 1% Uranyl Formate solution for 30–60 s.  
 
 
2.6 Clinical Study Design 
Informed consent was obtained from all participating subjects using written 
forms approved by the Institutional Review Board (IRB) at Boston Children’s 
Hospital. Patient eye was dilated prior to data collection using Phenylephrine 
(2.5%) and the accommodation of the lens was fixed using Tropicamide (1%). All 
data collection and storage was compliant with HIPAA conventions. 
 
2.6.1 Assessment of Molecular Aging  
Thirty-four human subjects, aged between 5 and 61 years were tested (18 
males and 16 females). Measurements were obtained from the nuclear region of 
the lens of the right eye. Data from each patient was acquired three times, with 
each scan constituting of five replicates. Each replicate comprised of an 
acquisition time of 0.22 s. 
 
2.6.2 Assessment of Alzheimer’s Disease-Related Protein Changes in 
Down Syndrome 
 
The Longwood Cohort 
 
Measurements were obtained from the supranuclear region of the lens, 
corresponding to the location of amyloid accumulation as seen previously [61]. 
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18 Control (11 male, 7 female, mean age: 15.5 y.o. ± 2.1) and 8 DS (5 male, 3 
female, mean age: 13.6 y.o. ± 2.1) subjects were part of the study cohort. Each 
measurement comprised of an acquisition time of 0.22 s. 
 
The Peabody Cohort 
Measurement parameters were the same (acquisition time of 0.22 s for 
each measurement from the supranuclear region). The cohort used for this study 
was larger: 16 Control subjects (6male, 10female, mean age: 12.44 y.o. ± 2.2) 
and 15 DS subjects (9male, 6female, mean age: 13.88 y.o. ± 3.35). 
 
 
2.7 Caveats and Limitations 
 
Quasi-Elastic Light Scattering and Particle Size Extraction 
 
The technique of quasi-elastic light scattering (QLS) calculates the 
diffusion coefficients and the mean scattering intensity of the scattering particles. 
The diffusion coefficient can then be used to compute the particle size. The 
dynamics of the scattering particles are related to the Brownian motion of the 
particles. Brownian motion is dependent on temperature and viscosity of the 
sample, and these parameters need to be stable in order to make accurate 
conclusions about the sample’s particle size distribution [96,113].  
In the in vitro studies discussed in this thesis work, all samples were kept 
in an incubator at 37°C. Prior to obtaining QLS measurements, samples were 
kept at room temperature (21°C) for 10 minutes to ensure that a change in 
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temperature over the course of data acquisition would not be a factor. Over the 
time range measured in the in vitro experiments, the overall viscosity of the 
samples is not expected to vary significantly. However, small local changes in 
viscosity as a result of particle aggregation or other molecular changes might be 
a factor that was not accounted for in our estimation of size distributions from the 
autocorrelation functions (ACF’s). 
For the in vivo data obtained in our studies, the temperature used for size 
distribution estimation was the human body temperature of 37°C. The viscosity in 
the human lens has been shown to change with age [15]. We used a constant 
value of 5.74 cP [116] for particle size extraction from ACF’s. Thus, the change in 
viscosity with age is a factor that was not accounted for in estimation of particle 
sizes of human lens proteins. 
Another caveat of QLS as applied in our setup is that it cannot differentiate 
between changes in size and shape of the scattering particles. Since 
conformational changes and structural modifications in proteins can also affect 
the diffusion speed, QLS, independently, is not able to separate the effect of 
modifications in particle size versus changes in conformation or shape. In future 
in vitro experiments, a technique such as 2D Gel Electrophoresis can be utilized 
to evaluate samples in parallel to QLS to provide better understanding of the 
molecular changes. 
As described in Chapter 2, computation of the particle sizes from the ACF 
is an “ill-posed” problem with potentially an infinite number of approximate 
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solutions. The different algorithms used to extract particle sizes provide the 
optimal solution from the spectrum of candidates. We applied non-negative 
truncated singular value decomposition (DYNALS) for particle size analysis. An 
important limitation of the size distribution analysis is that the width of the 
calculated distribution is dependent on both the polydispersity of the sample as 
well as the signal to noise ratio (SNR). If the input signal has greater noise, the 
estimation of the fit and hence the derived particle sizes display greater variance 
(width). One of the ways to mitigate this effect is to obtain QLS measurements 
with long acquisition times. This is of course easier to administer in in vitro 
experiments.  
 
Sample Preparation (in vitro) 
 
The protein concentration in the lens of the eye is the highest 
concentration in any tissue in the human body (350–500 mg/ml) [1,35,77]. The in 
vitro experiments using human lens proteins were carried out at concentrations 
of 1 – 5 mg/ml (Chapter 3). The reasons for monitoring this concentration range 
are discussed in detail in Section 1, Chapter 3. The disparity in concentrations 
used in vitro versus that in the eye in vivo is an experimental limitation of our 
studies. Moreover, for our in vitro experiments, we used only the water-soluble 
fraction of the human lens proteins. This is another caveat to consider while 
comparing in vitro and in vivo results, and in future studies, examining the water-
insoluble fraction should be considered. 
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Clinical Studies (in vivo) 
 
A general limitation of the QLS clinical studies conducted in relation with 
this research is the sample size of the patients. Having multiple patients at each 
age would allow for assessment of individual variability, an important concept in 
biological aging. Additionally, following patients longitudinally can be a factor to 
examine in future studies and is likely to provide better understanding of 
molecular events in the lens of the eye. 
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Chapter 3 
In Vitro Assessment of Age-Related Changes in Human Lens Proteins 
A number of theories have been proposed for molecular aging in the 
human body and the common theme involves damage and modifications to DNA 
and proteins [58, 123, 124]. As the body gets older, its ability to repair these 
damages decreases, resulting in accumulation and onset of pathology. The lens 
of the eye offers an ideal system to study age-related changes in constituent 
proteins due to this tissue’s optical transparency and accessibility from the 
periphery, the highly ordered spatial organization of the long-lived lens fiber cells, 
and absence of protein turnover in these same cells, which comprise the bulk of 
the lens [12, 13, 23]. Remarkably, the fiber cells in the embryonic nucleus of the 
lens (see Figure 1.2 – Chapter 1) contain crystallin proteins that were expressed 
before birth and will remain extant (and largely functional) after death [9, 125, 
126]. Crystallins are among a handful of proteins in the human body that persist 
for life; others include elastin, collagen, and dentine [38, 126].   
Protein synthesis and mitotic activity in the lens is restricted to a single 
monolayer of epithelial cells on the anterior surface (see Figure 1.2 – Chapter 1). 
During the terminal differentiation of the epithelial cells into lens fiber cells, a 
large amount of proteins, primarily crystallins get synthesized. Soon after 
formation, lens fiber cells lose their protein synthesizing machinery and other 
organelles, and get ordered into quasi-hexagonal arrays [20].  
While crystallins are remarkably stable, they do undergo a variety of well-
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characterized non-enzymatic post-translational modifications as a function of 
time during normal and pathologic aging, such as racemization, deamidation, 
phosphorylation, oxidation, glycation, and proteolytic cleavage [8, 32, 46, 57, 
126], among others. These modifications are exacerbated as a result of disease- 
and environment- related perturbations, including exposure to UVA, UVB, and X-
ray radiation, cigarette and cooking smoke, oxidative stress, and influence of 
metals [8, 30, 41, 43, 44, 57, 127, 128]. Assessment of age-related protein 
modifications in a system like the lens, using the sensitive technique of quasi-
elastic light scattering (QLS), can elucidate underlying molecular phenomena that 
characterize disease pathology and irregular aging patterns. As detailed in 
chapter 2 – section 1, QLS provides quantitative metrics that can describe the 
behavior of a complex mixture of particles: the mean scattering intensity is 
related to the average molecular weight of the scattering system, the mean value 
of correlation time from the computed autocorrelation function (ACF) is useful in 
characterizing the dynamics of the sample, namely the average diffusivity, and 
the ACF can also be used to extract the size distribution of the population of 
particles, which yields information about particles’ relative contributions to the 
signal. The in vitro approach permits design of experiments in controlled settings 
and allows physiologically relevant perturbations to be easily administered.  
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3.1 Pilot Study: Establishment of Experimental Parameters  
The in vitro experiments performed to study age-related changes utilized 
the water-soluble (cytosolic) fraction of human lens proteins. The concentration 
of proteins in the lens is the highest known in the human body (350–500 mg/ml) 
[1, 35, 77]. However, it is both technically and practically unfeasible to conduct in 
vitro studies at physiological concentrations. A review of literature suggests that 
the efficiency of extraction of the water-soluble (or water-insoluble) fraction is 
largely dependent on the type and volume of buffer used and the method used 
for extraction. This has led to the notion that the definition of the lens fractions is 
strictly operational in nature [27]. Through our protocol (see Chapter 2), the 
concentration of the extracted water-soluble fraction from a single lens is typically 
20–30 mg/ml. Briefly, our protocol involves homogenizing the lens in 0.8–1 ml of 
DI water and ultracentrifuging the homogenates at 4°C for 1 hr at 100,000 g’s. 
The supernatant is the water-soluble fraction. 
We expect to monitor the changes in protein states over time, and 
hypothesize that modifications will result in increase in light scattering. Hence, it 
would be appropriate to use a protein concentration that demonstrates changes 
at a suitable rate. Another factor in determining a viable concentration to use are 
the limitations inherent to QLS. The theory behind QLS applies most effectively in 
dilute solutions or suspensions of particles, without considerable particle-particle 
interactions. Finally, QLS studies, in literature, have used lens crystallins at a 
wide range of concentrations (0.3–20 mg/ml). We decided to perform this pilot 
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experiment at 2 concentrations: 1 mg/ml and 5 mg/ml, and we hypothesize that 
over time, a higher concentration will produce a greater rate of change in light 
scattering based on previous research in the field. For this experiment, the left 
lens from a 62 year-old male was used, and the concentration of the water-
soluble fraction was determined by the BCA protein assay to be 25 mg/ml. One 
sample, each at 1 mg/ml and 5 mg/ml, were made by dilution of the extracted 
supernatant in Phosphate Buffered Saline (no Ca2+, no Mg2+). QLS 
measurements on the 1 mg/ml and 5 mg/ml samples were done using a volume 
of 600 µL in a cylindrical glass cuvette. The protein samples were incubated in 
the dark at 37°C, and were brought to room temperature before measurements 
were performed (see Chapter 2 for more details). This is the first time, in our 
knowledge, that the total water-soluble (cytosolic) fraction of human lens proteins 
was monitored for time-dependent changes using QLS for a duration as long as 
140 days. The size distribution analysis was done using a viscosity of 1 cP, 
corresponding to PBS.  
As hypothesized, changes in light scattering occurred at a higher rate for 
the 5 mg/ml sample compared to 1 mg/ml. For both scattering intensity (Figure 
3.1) and correlation time (Figure 3.2), increase in concentration produced a 
significant increase in rate over time. The initial nucleation or lag phase for mean 
scattering intensity visible in the 1 mg/ml sample is negligible in the case of 5 
mg/ml, which shows almost immediate exponential growth. After approximately 
40 days, lens proteins at the lower concentration start demonstrating an increase 
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in mean scattering intensity. In Figure 3.2, the correlation time for lens proteins at 
5 mg/ml at the onset of the experiment is considerably higher than for the sample 
at 1 mg/ml. Both samples display an increase in correlation time; however, the 
rate of increase in the sample at higher concentration is exponential compared to 
the sigmoidal growth seen for 1 mg/ml.  
 
 
 
Figure 3.1: At a higher concentration, scattering intensity in lens proteins increased at a 
higher rate over time. Error bars signify standard deviation from the mean calculated 
from 15 measurements done on 1 sample. 
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Figure 3.2: Correlation time index increases at a higher rate over time for 5 mg/ml. Error 
bars signify standard deviation from the mean calculated from 15 measurements done 
on 1 sample. 
 
From the ACF’s, particle size distributions at two time points for the two 
samples were extracted. Time points of day 1 and day 76 were chosen to 
compare the effect of time and concentration on the protein distributions (Figures 
3.3a and 3.3b). These time points were chosen based on the behavior of 
scattering intensity and correlation time as a function of time. Day 1 denotes the 
start of the experiment, and by day 76, differences between the two samples are 
evident. On day 1, the low concentration protein sample shows a broad size 
distribution while the sample at 5 mg/ml displays presence of two peaks, which 
overlap at ~50 nm. By day 76, significant changes to the protein distribution are 
apparent. The protein population shows a shift towards larger hydrodynamic radii 
over time when compared with day 1. For both 5 and 1 mg/ml concentrations, a 
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unimodal distribution is noted for the lens proteins. However, the sample at the 
higher concentration displays a greater shift towards larger hydrodynamic radii.  
 
 
 
 
Figure 3.3a: Size distributions extracted from the samples on day 1 of the experiment. 
 
 
 
Figure 3.3b: Size distributions extracted on day 76 of the experiment show a significant 
shift towards larger particle sizes for the 5 mg/ml sample. 
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In this pilot study to establish experimental parameters, we followed time-
dependent changes in light scattering behavior of the water-soluble portion of 
human lens proteins at two concentrations: 5 mg/ml and 1 mg/ml. An effect of 
concentration on the rate of change in mean scattering intensity and correlation 
time was noted. To the best of our knowledge, this is the first time a complex 
mixture or total water-soluble human lens proteins has been studied using QLS 
for such an extensive period of time. The ability to assess cytosolic human lens 
protein changes in a long-term time-dependent manner suggests that this in vitro 
model system can be utilized to reflect the age-dependent changes seen in vivo 
in the human lens. This experiment was also successful in determining the 
boundary conditions for an appropriate concentration range. At the lower end, for 
1 mg/ml, a gradual increase with an initial lag phase is observed, while there is 
immediate exponential growth for 5 mg/ml. It is reasonable to expect that 
concentrations much lower than 1 mg/ml might produce very slight or no 
observable changes in QLS signal for an impractically long period of time. 
Conversely, at concentrations higher than 5 mg/ml, the rate of change might be 
so rapid that early-stage molecular events wont be discernible. Thus, all 
subsequent experiments were carried out at concentrations within this range. 
In the 5 mg/ml sample, we see exponential growth from the onset of the 
experiment. It is likely that this happens due to an increase in secondary 
nucleation, growth, and fragmentation reactions. At a higher concentration, 
dependence on ‘monomers’ or small oligomeric species to initiate primary 
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nucleation is reduced [76, 129, 130]. On the other hand, in the 1 mg/ml sample, 
the major reactions in the initial lag phase are likely primary nucleation events. 
The higher value of correlation time on day 1 for 5 mg/ml indicates the presence 
of pre-existing aggregates, which can drive the aggregation process at a faster 
rate. Particle size distribution plots (Figures 3.3a and 3.3b) confirm the higher 
rate of aggregation in the 5 mg/ml sample. In summary, this pilot study 
established the protein concentration boundaries as well as other relevant 
parameters such as extraction protocol, appropriate buffer system, and ability of 
our QLS system to detect time-dependent molecular changes, for subsequent 
experiments in this chapter. The next section replicated and extended this study, 
and demonstrated similar results. A more rigorous discussion on possible 
explanations of the observations is provided in the next section.  
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3.2 Time Dependent Effects 
In an effort to replicate the findings in the pilot study discussed in the 
previous section, light scattering changes in the water-soluble (cytosolic) fraction 
of human lens proteins was monitored over time. Upon review of literature, to the 
best of our knowledge, the long-term effect of time, as a perturbation, on 
changes in lens protein behavior using quasi-elastic light scattering (QLS) has 
not been studied till date. Biological aging can be broadly categorized into 
modifications to DNA, which bring about cellular senescence [131], and post-
translational modifications (PTM) to proteins. In particular, alterations to long-
lived proteins have been noted to be determinants in the aging process [9, 126]. 
This chapter focuses on the latter, and specifically on the long-lived proteins in 
the lens of the eye – the crystallins. PTM’s, such as racemization, deamidation, 
phosphorylation, oxidation, truncation, among others, are some of the age-
related changes to the proteome [18, 33, 41, 76, 118, 127, 128, 132]. These 
alterations result in loss of certain species and gain of others [7, 12, 13, 30, 32, 
57, 119]. Changes to the protein environment are preserved in the lens because 
there is no turnover of proteins [125], thus providing a system to study 
accumulation of damage over time.  
Lens proteins have been extensively studied in vitro [12, 43, 95, 96, 98]. 
This section investigated the effects of long-term incubation of human lens 
proteins in vitro as a model system for advancing age of the lens in vivo. The 
technique of QLS was used to detect time-dependent modifications in protein-
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protein interactions and protein aggregation. In this experiment, we hypothesize 
that we will see age-dependent changes in light scattering properties in the 
aqueous solution of human lens proteins. The left lens of a 77 y.o. female was 
used for extraction of the proteins. The concentration of the water-soluble 
fraction, as determined by the BCA protein assay, was 34 mg/ml, and this was 
utilized to make 3 samples at 1 mg/ml. Cylindrical glass cuvettes were used with 
600 µL of the protein solution. The samples were kept at the physiologically 
relevant temperature of 37°C and prior to QLS measurements, were brought to 
room temperature (by placing in the measurement room for 15 minutes). There 
were 15 replicates obtained for each sample at each time point. After every 5 
replicates, the cuvettes were rotated. This mitigated chances of all 
measurements to be affected by artifacts, such as blemishes on the glass 
surface, and resulted sampling from more than one confocal region. The 
acquisition time for each replicate was 3 s. For more details on the methodology, 
please refer to Chapter 2. 
Results are presented in Figures 3.4 through 3.5. Remarkably, we were 
able to follow protein behavior as a function of time for nearly 1 year (330 days).  
We noted that samples go through two major phases with different kinetics for 
both average scattering intensity (Figure 3.4) and correlation time (Figure 3.5). 
The initial nucleation or lag phase extends from day 1 till approximately day 60, 
followed by an apparent inflection point, beyond which intensity and correlation 
time increase rapidly (phases separated by the black dashed line in Figures 3.4 
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and 3.5). The initial phase in scattering intensity had a slope of 0.05 and did not 
show statistically significant change with time. A single exponential growth model 
with a correlation coefficient of 0.98 was used to fit the second phase. The slope 
was 1110.8 counts per sec/day (cps/day) and the effect of time on scattering 
intensity was statistically significant (p-value = 8.11e-28). Linear regression 
analysis was applied to calculate significance. The behavior of correlation time in 
the first phase displayed an initial reduction in values before a period of lag. The 
change in correlation time in the first phase was not significant as a function of 
time (p-value = 0.32). The second period (from approximately day 60 to day 330) 
showed linear growth. The trend was described by a linear function with a 
correlation coefficient of 0.98. Statistical significance of the effect of time on 
change in correlation time was noted at a p-value of 2.83e-31, and the slope was 
calculated to be 0.001 ms/days. The variance in the mean values for correlation 
time is also seen to reduce as a function of time. While this is certainly a result of 
an increase in scattering intensity, which reduces fluctuations in the correlator 
channels, the relatively sudden manner in which this change happens around the 
apparent inflection point is of considerable interest. This occurrence might be 
reflective of the underlying molecular behavior. The variance in the mean values 
for scattering intensity did not display such a trend. 
  
63 
 
 
Figure 3.4: Increase in scattering intensity of light in water-soluble human lens proteins 
as a function of time. Exponential fit (R2 = 0.98 (red)) used to describe aggregation 
behavior. Two major periods with different kinetics observed. Apparent inflection point 
noted at approximately 60 days (separated by black dashed line). Error bars signify 
standard deviation from the mean obtained from measurements on 3 replicate samples. 
     
 
 
Figure 3.5: Increase in correlation time of water-soluble human lens proteins as a 
function of time. Exponential fit (R2 = 0.98 (red)) used to describe aggregation behavior. 
Two major periods with different kinetics observed. Apparent inflection point noted at 
approximately 60 days (separated by black dashed line). Error bars signify standard 
deviation from the mean obtained from measurements on 3 replicate samples. 
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The ACF can be utilized to provide information about the scattering 
system’s protein size distribution. The increase in scattering intensity and 
correlation time over time suggest a net aggregation process resulting in 
formation of high molecular weight protein aggregates. In Figure 3.6, the size 
distributions at three representative time points are compared. There is a shift 
towards larger hydrodynamic radii in the distribution from day 56 through day 154 
to day 303. The smaller sized components, represented by the first peak 
centered on 1 nm, appear to reduce with time as the distribution assumes a 
unimodal shape. 
  
 
 
Figure 3.6: Extracted particle size distribution is seen to shift towards larger 
hydrodynamic radii as a function of time. 
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In this experiment, the major findings are summarized below: 
i) Long-term (~ 1 year) incubation of a complex mixture of water-soluble 
human lens proteins is possible to study in an in vitro system. 
ii) Time-dependent changes were detected in lens proteins in vitro that 
are consistent with age-dependent changes in the human lens in vivo. 
iii) Complex kinetics in mean scattering intensity and correlation time were 
observed, which suggested changes in the behavior of proteins. 
iv) Two periods with different kinetics in both scattering intensity and 
correlation time were noted. 
v) Changes in QLS signals corresponded with apparent changes in 
underlying protein distributions with respect to hydrodynamic radii. 
This study evaluated long-term time-dependent changes in a very 
complex polydisperse mixture of water-soluble lens proteins, a good 
approximation for the protein milieu in the cytosol of the long-lived lens fiber cells. 
In such an environment, there are possibly numerous molecular mechanisms 
that occur to generate the noted observations. Here, we discuss possible 
explanations for the findings. We hypothesize that the first phase with slow rate 
kinetics, in both scattering intensity and correlation time, involves primary and 
secondary nucleation reactions. Within the initial period of the first phase, evident 
in correlation time, the reaction rate is negative. This could be a result of 
molecular reorganization, and fragmentation and precipitation of large pre-
existing protein oligomers. Over approximately 60 days, there is a slow growth 
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rate observed, which can result from nucleation, association of small oligomers 
with each other, and elongation of oligomers. Nucleation can be both secondary 
– addition of monomers onto the surface of oligomers, or primary – formation of 
oligomeric species from monomers [76, 129, 130, 133]. Since most lens protein 
species do not natively exist as monomers, nucleation is likely to be mostly 
secondary. There can be γ-crystallins, which typically exist as monomers, 
participating in nucleation events. Oligomeric elongation could involve 
association of smaller protein species to pre-existing aggregates. Once a critical 
transition point and mass is reached, the probability of association increases and 
reactions are likely to be dominated by extension of aggregates and 
fragmentation to produce smaller aggregates that then associate with other 
forms. This results in a rapid growth rate as seen in the second major phase in 
the plots. The correlation time of a sample with potentially a broad spectrum of 
particle sizes is representative of the population’s mean behavior. The increase 
in correlation time signifies an increase in mean population size. The particle size 
distributions extracted from the intensity autocorrelation functions confirmed this 
increase through the shift towards larger hydrodynamic radii with time. There was 
also loss of the smaller sized protein population observed. These data are 
indicative of molecular events that might be occurring in the aging lens, where 
the fraction of soluble low-molecular weight components gradually decreases 
and the percentage of proteins existing as high-molecular weight aggregates 
increases. For instance, almost all the soluble α-crystallin has been shown to 
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associate into large oligomers and finally become insolubilized [13]. The 
inversion of an ACF to generate the underlying particle distribution is a 
complicated analytical problem, and is discussed in detail in Chapter 5. In vitro 
experiments in dilute aqueous conditions reduce the concerns of particle-particle 
interactions and effect of high viscosity on the protein molecules. Another caveat 
while using information obtained from the size distributions is that the width of the 
peak can be influenced not only by polydispersity, but also by the error in 
measurement. Collecting data from multiple replicate samples, using longer 
acquisition times, and conducting multiple measurements can all serve to 
improve data quality. 
These results suggest that molecular aging of long-lived lens proteins can 
be studied long-term in vitro and models the age-related changes to proteins in 
the living lens. The water-soluble fraction, which comprises 90% of the total 
protein in the lens, is a good approximation to the protein environment in vivo in 
the lens fiber cells. Consistent with vast literature in the field, this study 
demonstrates aggregation and protein-protein interactions that result in a 
transition of low molecular weight aggregates into high molecular weight 
aggregates. The bi-phasic aggregation kinetics also follows what has been 
observed in vivo.  
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3.3 Exposure to X-Ray Radiation  
The lens’ optical accessibility also, unfortunately, exposes it to harmful 
environmental stimuli such as radiation energy. Radiation damage can occur 
from both ionizing (γ-rays, X-rays, far-UV) and non-ionizing sources (near-UV, 
visible light, IR), with the former having more potential for harm; changes brought 
about by ionizing radiation as a perturbing factor will be the focus of this section. 
Exposure to radiation has been shown to increase cataractogenesis, generate 
reactive oxygen species, which in turn cause oxidative damage, promote 
unfolding of proteins and cross-linking, and truncation (34–36). Radiation also 
induces harmful effects in DNA in lens epithelial cells producing cataracts that 
are maintained as the fiber cells get formed, and causes changes to the cell 
differentiation process [118]. The quantification of ionizing radiation energy is 
done using Geiger counters that measure levels in the air or on the surface of 
tissue. Using QLS, the effect of radiation within tissue can be measured. 
Moreover, as a result of the absence of protein turnover in the lens fiber cells, 
radiation-dependent damage accumulates and the cumulative effect can be 
observed. 
The previous section investigated the long-term effect of time-dependent 
changes in an in vitro model of water-soluble human lens proteins. In this 
section, we build on that model by adding the variable of radiation energy. The 
technique of QLS is applied to monitor radiation-induced changes in protein-
protein interactions, protein conformation, and aggregation. It is hypothesized 
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that irradiation of lens crystallins will result in an increase in light scattering over 
time. Furthermore, when compared to untreated crystallins, the rate of increase 
in light scattering in irradiated crystallins is expected to be higher. To test these 
effects, the water-soluble fraction of human lens proteins extracted from the left 
lens of a 62 y.o. male was utilized. Concentration of the extracted supernatant 
was determined by the BCA protein assay to be 25 mg/ml. One sample was 
made at 1 mg/ml (in Phosphate Buffered Saline without Ca2+ and Mg2+) and 
exposed to a single dose of X-ray radiation (340 Gy). The untreated control 
consisted of 1 sample at 1 mg/ml. Both samples were followed using QLS over 
140 days. At each time point, 15 measurements were obtained and the 
acquisition time for each measurement was 3 s. Size distribution analysis was 
done with a viscosity of 1 cP (for more details on the methodology, please refer 
to Chapter 2). Previous studies on radiation damage to lens proteins have been 
conducted with a wide range of doses, and have examined radiation-dependent 
changes on both fractionated crystallin classes and the total water-soluble 
extract. We decided to use an X-ray radiation dose reported in an earlier study 
on the water-soluble fraction of bovine lens proteins [119]. The experiment 
discussed in this section is the first attempt at evaluating the long-term effect of 
X-ray irradiation on water-soluble human lens proteins. 
The changes observed in the parameters of mean scattering intensity and 
correlation time as a function of time are presented in Figures 3.7 and 3.8, 
respectively. The mean scattering intensity displays similar sigmoidal behavior 
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for both control and irradiated samples, but it increases at a higher rate in the 
irradiated case. There is an initial nucleation phase noted for both samples that 
extends till approximately 20 days from the onset of the experiment. This is 
followed by a period of exponential growth, and at approximately day 120 the 
curves appear to reach a saturation phase. The rate of increase for mean 
scattering intensity of the irradiated samples was calculated, by linear regression, 
to be 947.48 cps/day, while for the control the rate was 589.16 cps/day. 
Comparison of change in correlation time as a function of time denotes the 
presence of a first phase that lasts till approximately day 20 and suggests a 
period of nucleation events. From day 20 onwards, the rate of change in the 
radiated sample exceeds the control. The slopes computed by linear regression 
were 0.002 ms/day and 0.001 ms/day for irradiated and control respectively. We 
also noticed that the variance of the mean correlation time decreases as a 
function of time for both sample types. 
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Figure 3.7: Effect of X-irradiation on average scattering intensity of water-soluble human 
lens proteins. The lens was obtained posthumously from a 62 y.o. male. Error bars 
represent standard deviation from the mean calculated from 15 measurements done on 
one sample. 
 
 
 
 
Figure 3.8: Effect of X-irradiation on correlation time of water-soluble human lens 
proteins. The lens was obtained posthumously from a 62 y.o. male. Error bars represent 
standard deviation from the mean calculated from 15 measurements done on one 
sample. 
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A greater rate of increase in scattering intensity and correlation time for 
the irradiated sample suggests that the rate of aggregate formation is higher 
compared to the untreated control. When particle size distributions are analyzed 
at different time points, the increase in mean particle size of the proteins is 
further confirmed (Figure 3.9a–c). On day 9, the irradiated and control samples 
have similar broad distributions. By day 63, the distributions for the two samples 
have assumed a primarily unimodal shape. The third time point examined was on 
day 125; we note that the peak centers have shifted towards larger 
hydrodynamic radii, with a greater shift for the irradiated distribution. There is 
also presence of a small peak in the lower molecular weight region for the 
irradiated case. 
 
 
 
Figure 3.9a: Particle size distributions on day 9 show significant overlap between control 
and irradiated samples. 
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Figure 3.9b: Particle size distributions of control and irradiated samples on day 63. The 
distributions have assumed a unimodal shape. 
 
 
 
 
Figure 3.9c: Particle size distributions of control and irradiated samples for day 125 show 
a shift towards larger sizes for the lens proteins exposed to radiation. There is also 
presence of a smaller peak, which likely represents particles with smaller hydrodynamic 
radii. 
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An interesting result was observed by an increase in concentration on the 
effect of radiation on water-soluble human lens proteins. At a higher 
concentration of 5 mg/ml and on exposure to the same dose of X-irradiation, for 
the same lens, the differences observed between control and radiated samples 
for scattering intensity (Figure 3.10) and correlation time (Figure 3.11) over time 
were negligible. This effect might be due to a concentration-dependent increase 
in the ability of lens proteins to cope with damage brought about due to radiation. 
 
 
Figure 3.10: At a concentration of 5 mg/ml, the effects of radiation on average scattering 
intensity of lens proteins are significantly mitigated. Error bars signify standard deviation 
from the mean calculated from 15 measurements done on 1 sample. 
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Figure 3.11: At a concentration of 5 mg/ml, the effects of radiation on correlation time of 
lens proteins are significantly mitigated. Error bars signify standard deviation from the 
mean calculated from 15 measurements done on 1 sample. 
 
 
A summary of the major findings in this section is as follows: 
i) The study of long-term effects of time and radiation damage is possible 
in a complex polydisperse in vitro system of water-soluble (cytosolic) 
human lens proteins. 
ii) Time-dependent increase in rate of scattering intensity and correlation 
time was seen for both irradiated and control samples. 
iii) An increase in rate of scattering intensity and correlation time was 
noted for the irradiated sample compared to control. 
iv) There are two major phases observed: a nucleation or lag phase and 
an exponential growth phase that appears to saturate towards the final 
15% of the total duration of the experiment. 
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v) Extracted particle size distributions for the two samples are similar in 
the nucleation phase. 
vi) Over the course of the experiment, the size distributions for both 
control and irradiated samples shift towards larger particle sizes, and 
this shift is greater for the irradiated case. 
Exposure to radiation has been noted to produce variable effects on the 
different types of crystallins present in the lens [117–120]; however, there is less 
agreement, in literature, on the types of changes. Here, we studied the long-term 
effects of exposure to X-ray radiation on the water-soluble fraction of human lens 
proteins. The lens is well equipped to cope with levels of radiation normally 
observed over the course of aging. Presence of radioprotective molecules like 
thiols, ascorbates, and UV-filters, chaperoning activity of α-crystallin to limit 
aggregation, absorption of harmful radiation by the cornea, and the high packing 
density of crystallins in the fiber cells all serve to mitigate the effects of low-dose 
radiation [119]. However, if the lens is subjected to a high amount of radiation or 
chronic exposure, there are many harmful changes that take place. Through the 
QLS results, we observe that radiation-induced damage leads to an increase in 
the average scattering intensity, diffusion coefficient or correlation time, and 
particle sizes. The size distribution shifts towards larger particles as a function of 
time. These changes suggest aggregation events that lead to an increase in the 
proportion of high molecular weight protein species. This observation is 
consistent with previous experiments in literature. Irradiation has been shown to 
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induce oxidative stress in cells through generation of hydrogen peroxide and 
superoxide, which can lead to unfolding of proteins. In the presence of metals, 
due to the Fenton reaction, oxidative damage is exacerbated by production of 
hydroxyl radicals [117]. Radiation also causes cross-linking and truncation of 
proteins [119]. The presence of the smaller peak in the particle distribution of the 
irradiated sample might represent truncated protein forms. In the presence of a 
higher proportion of unfolded or fragmented proteins, aggregation reactions can 
occur with greater probability. α-Crystallin is known to sequester partially folded 
or unfolded proteins leading to formation of higher molecular weight oligomers. 
This molecular chaperoning also results in a decline in levels of soluble α-
crystallins. Additionally, conformational changes caused by radiation can lead to 
proteins associating into larger oligomers. While the technique of QLS is effective 
in detecting early-stage molecular changes, it does not permit discerning 
between the various mechanisms that lead to aggregation. 
In summary, in this section, we were able to perturb the complex water-
soluble human lens protein mixture with X-ray radiation and monitor the long-
term effects of radiation damage on protein behavior. Historically, research on 
radiation-dependent changes to proteins (and DNA) has been motivated by the 
effect of space travel on astronauts. Due to increase in the incidence of diseases 
requiring radiation therapy, the potential for exposure of the public to radiation in 
the event of an industrial disaster, and the general increase in environmental UV 
radiation due to climate change, studies that monitor accumulated changes in 
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tissue become relevant. Here, we demonstrate that the technique of QLS can be 
applied to detect long-term radiation-induced modifications in the protein 
environment of the human lens.  
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3.4 Oxidation-Based Accelerated Aging Model 
Age-related changes in the molecular environment can be caused by 
various mechanisms. Oxidative stress is a commonly accepted mechanism for 
molecular aging, and produces extensive post-translational modifications (PTM), 
such as degradation, nondisulfide cross-linking, and carbonylation, among 
others, in proteins [40, 44, 134]. This section discusses the effect of perturbing 
the long-lived lens crystallin proteins with reactive oxygen species (ROS) 
generated by the metal-catalyzed Fenton reaction, resulting in oxidative damage. 
The absence of protein turnover in the lens fiber cells leads to accretion of 
modifications [8, 13, 38, 135] and allows detection via quasi-elastic light 
scattering (QLS).  
The lens is exposed in vivo to a high level of oxidative stress, both from oxidants 
present in the surrounding aqueous and vitreous humors and from oxidants 
generated within the lens [13, 41, 128]. To curb the effects of protein oxidation, 
the lens has a number of safety features. Level of the antioxidant, glutathione, in 
the lens is one of the highest in the body [13]. It is actively synthesized in the 
outermost cortical cells. There is also an inherent lack of need for high quantities 
of oxygen in the mature lens fiber cells due to absence of protein synthesizing 
machinery. Photo-oxidation is minimized since the cornea hardly transmits any 
light below 300 nm, and small-molecule UV filters based on metabolites of 
tryptophan that are present in the lens absorb radiation in the 300–400 nm range 
(UVA) [13]. However, as the lens ages, so does its vulnerability to oxidative 
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damage. Levels of free small-molecule UV filters have been shown to decrease 
linearly with age at 12% per decade [13], and covalent complexes formed 
between these filters and crystallin proteins increase with age. These modified 
complexes tend to absorb more UVA, rendering the lens susceptible to photo-
oxidative damage. The level of glutathione also decreases with age as a result of 
lowered rate of synthesis and higher rate of consumption. Moreover, free radical 
scavenging systems like the enzyme Glutathione peroxidase show reduced 
presence in the aging lens [13, 44, 136]. Another effect of aging is the 
insolubilization of crystallins, which causes stiffening of the cell layers, 
particularly in the nucleus, compromising cellular transport of small molecules 
through gap junctions. This results in further decrease of glutathione levels in the 
central portion of the lens since synthesis takes place in the outer cortex. As a 
consequence of these changes, oxidative damage becomes more pertinent. The 
effect is enhanced if lens proteins are exposed to higher levels of oxidative stress 
in the case of diseases like Alzheimer’s or due to lifestyle choices [18].  
In order to detect the alterations in the protein environment associated 
with oxidative damage, an in vitro accelerated aging model was evaluated using 
QLS. The long-lived human lens proteins were exposed to an acute level of 
oxidative stress produced by the metal-catalyzed generation of hydroxyl radicals, 
and the effects were monitored over 77 days. Additionally, QLS findings were 
validated by analyzing the oxidized and control samples with techniques of 
protein gel electrophoresis and transmission electron microscopy. In these 
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experiments, we hypothesize that oxidation will result in changes to protein 
structure and function, affect protein-protein interactions, and increase the rate of 
aggregation. These modifications to the state of the lens proteins will be 
detectable using QLS, and the findings corroborated by two biochemical 
independent techniques – protein gel electrophoresis (PGE) and transmission 
electron microscopy (TEM). 
Details of the methods involved are explained in detail in Chapter 2. 
Briefly, water-soluble lens proteins were extracted from the right lens of a 75 y.o. 
female; the concentration of the extract was 30 mg/ml. The QLS experiment was 
carried out using 3 sample replicates each for control (untreated) and oxidized 
(treated to oxidative stress) of lens proteins at a concentration of 2.5 mg/ml 
(diluted in Phosphate Buffered Saline, without Ca2+ and Mg2+). Oxidative stress 
was induced through the Fenton reaction: in the presence of Fe2+ and EDTA 
(Ethylene Diamine Tetra Acetic Acid), H2O2 (hydrogen peroxide) gets converted 
into OH• (hydroxyl radicals). The short-lived, highly reactive hydroxyl radicals 
have been shown to be extremely toxic in the intracellular environment [121]. At 
each time point, 15 measurements were obtained from every sample; the 
acquisition time for each measurement was 10 s. A viscosity of 1 cP was used 
for computation of particle size distributions. PGE and TEM were done on 
aliquots of replicates of the samples used for QLS at various time points along 
the experiment. 
The average scattering intensity data are presented in Figure 3.12. 
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Compared to the untreated lens protein, the oxidized sample displays a rapid 
increase in scattering intensity as a function of time. There is a distinct nucleation 
phase observed for the control samples till approximately day 40, which is not 
present in the oxidized case. The rate of change in scattering intensity for 
untreated lens proteins was computed to be 787.51 cps/day. The oxidized 
sample, on the other hand, demonstrates exponential reaction kinetics from day 
1 till approximately day 60, followed by a period of slower increase. Rate of 
change for the oxidized lens proteins was calculated to be 1.23e4. The behavior 
of the protein population’s correlation time is more complex (Figure 3.13). As the 
molecular environment reorganizes in the initial 10 days, we see a negative rate 
change in correlation time for both control and oxidized samples. This initial 
decrease is more rapid in the oxidized sample. Following this period, the 
correlation time increases in a linearly dependent manner as a function of time 
(rate of change for this period is 0.003 ms/day). The negative rate change in 
correlation time for control samples stabilizes at approximately day 40.  
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Figure 3.12: Change in scattering intensity in control and oxidized samples as a function 
of time. Error bars represent standard deviation from the mean calculated from 
measurements of 3 replicate samples. Vertical dashed lines and the first time point (day 
1) signify days for which PGE and TEM data is presented in Figures 3.17a–c. 
 
 
 
 
Figure 3.13: Change in correlation time (Tau) control and oxidized samples over time. 
Error bars represent standard deviation of the mean calculated from measurements of 3 
replicate samples. Vertical dashed lines and the first time point (day 1) signify days for 
which PGE and TEM data is presented in Figures 3.17a–c. 
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In order to validate results from QLS, the techniques of PGE and TEM 
were applied. Figures 3.14a–c show data from three time points along the course 
of the experiment – days 1, 36, and 77 (also marked with black dashed lines in 
Figure 3.12 and 3.13). In the gels and associated gel intensity plots (Figures 
3.14a–c, left), we find that there is increase in high molecular weight species and 
decrease in low molecular weight species in the oxidized samples over time, 
compared to the control sample. There is also a broader spectrum of protein 
forms in the higher molecular weight ranges in the oxidized sample as observed 
by the smear along the gels. Reorganization in the protein environment over time 
can also be observed in the TEM images (Figures 3.14a–c, center and right). In 
accordance with results from the other techniques, the control and oxidized lens 
protein samples display similar molecular states on day 1 of the experiment. With 
time, as the control sample stabilizes, the oxidized sample forms oligomeric 
fibrillar aggregates. 
 
    
Figure 3.14a: Protein gel electrophoresis along with gel intensity distribution plots 
comparing control and oxidized samples on day 1. Intensity distribution plots are 
normalized against total intensity for that sample. Transmission electron microscopy 
images compare control and oxidized samples. Scale bar = 200 nm for all images. 
Control Oxidized 
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Figure 3.14b: Protein gels along with gel intensity distribution plots and TEM images 
comparing control and oxidized samples on day 36. Intensity distribution plots are 
normalized against total intensity for that sample. Transmission electron microscopy 
images compare control and oxidized samples. Scale bar = 200 nm for all images. 
 
   
Figure 3.14c: Protein gels along with gel intensity distribution plots and TEM images 
comparing control and oxidized samples on day 77. Intensity distribution plots are 
normalized against total intensity for that sample. Transmission electron microscopy 
images compare control and oxidized samples. Scale bar = 200 nm for all images. 
 
The major findings from the examination of oxidative damage to human 
lens proteins are: 
i) The effects of oxidative stress can be monitored long-term in an in vitro 
accelerated aging model of polydisperse water-soluble human lens 
proteins using QLS. 
ii) QLS results corroborate with the results obtained from PGE and TEM. 
Control Oxidized 
Control Oxidized 
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iii) Oxidation damage is detected by QLS as an increase in scattering 
intensity and correlation time. These changes are manifested as high-
molecular weight species in PGE and fibrillar aggregates in TEM. 
iv) The observations in this section are consistent with findings in previous 
studies done in vitro [121, 135, 137] and proposed mechanisms of 
oxidative damage in vivo [138–141].  
Here, the water-soluble human lens protein fraction was exposed to 
hydroxyl radicals in order to simulate high oxidative stress conditions, and can be 
considered as an in vitro model of accelerated aging. The experimental 
conditions were considerably different from those present in the lens in vivo. For 
instance, H2O2 concentrations in the in vitro system here were 10–40 times 
greater and the protein concentration was reduced 100–200 fold [121]. However, 
it is important to remember that modifications caused due to oxidation in 
crystallins in vivo are chronic effects that accumulate for decades. Hence, in 
order to empirically detect changes in a reasonable time frame, it is pragmatic to 
increase the level of oxidative stress on the system [121]. Oxidative damage can 
be brought out in a protein system in various methods. The exponential increase 
in scattering intensity in the oxidized lens proteins suggest reactions that are 
driven by elongation of pre-existing aggregates. Since average scattering 
intensity does not provide information on the dynamics of the molecular system, 
it is likely that the protein environment throughout the experiment is highly 
complex. This notion is supported by the changes in correlation time. The initial 
  
87 
decrease can be attributed to the various deleterious effects of oxidative-stress-
dependent carbonylation, a modification of native amino acid side chains to the 
carbonyl group. Carbonylation can cause misfolding, loss of function, and 
degradation [44]. As the protein environment stabilizes, with respect to protein-
protein associations, the correlation time and hence mean diffusivity stabilizes. 
However, due to the continued presence of hydroxyl radicals, the oxidized 
sample starts forming larger protein aggregates, resulting in an increase in 
correlation time. It has been shown in vitro that oxidative stress reduces the 
chaperone activity of α-crystallins by modifications of the amino acid sequence, 
which affects structure and conformation [142]. This alteration compromises the 
ability of the lens to mitigate aggregation resulting in formation of high-molecular 
weight species. We noted the presence of high-molecular weight protein forms in 
gels as well as in the form of fibrillar aggregates on the TEM images. 
Additionally, due to oxidative modifications caused to lens proteases, unfolded 
and damaged proteins are likely to accumulate causing an increase in light 
scattering, as observed in this experiment.  
Protein stability and resistance to oxidative damage has been suggested 
as being key factors in determining longevity [8]. The link between oxidative 
stress and diseases is of two types: consequential or causative, and there is 
evidence of both [135]. While post-translational modifications due to reactive 
oxygen species (ROS) occurs throughout the proteome, changes to lens proteins 
are preserved and thus constitute an ideal system for observation. It has been 
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postulated that the effect of oxidation might be an early marker for disease 
pathogenesis [8]. As an example, elevated levels of oxidation products, protein 
carbonyls, were found in people with mild cognitive impairment, a condition that 
often precedes Alzheimer’s disease. Increased carbonyl content is also seen in 
young diabetic patients without manifested complications [44]. In summary, an in 
vitro hydroxyl-radical-mediated accelerated aging model of human lens proteins 
can be investigated using QLS and techniques such as PGE and TEM to 
determine oxidation-dependent damage seen in vivo in the human lens. 
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3.5 Incubation with Zn2+ 
Metals are involved in a vast number of important roles in the functioning 
of the body: muscular contraction, cell permeability, protein stability, as co-factors 
and catalysts for enzymatic reactions, among others [143, 144]. Their association 
with diseases and processes such as pathogenic protein aggregation has also 
been researched [136, 143–153]. In the lens of the eye, there are a number of 
different metals that have been found performing important functions – Na+, Ca2+, 
Cu2+, and Zn2+. In this section, we examine the influence of Zn2+ as a 
perturbation factor in time-dependent modifications to human lens proteins in 
vitro as a model system for its role in the lens in vivo. Zinc is also the most 
abundant of trace elements in the human body, and has been known to mediate 
protein behavior in the lens [153]. Zinc’s effect on age-dependent changes to 
human lens proteins can be distinguished into its role in metal-catalyzed 
oxidation [147] and its interaction with α-crystallin [154]. Zn2+ has a significant 
influence on the stability and chaperone function of α-crystallin, which over the 
course of aging helps maintain transparency of the lens [144, 150]. Multiple Zn2+ 
ions (3-4) bind to each subunit of α-crystallin increasing its conformational 
stability [143, 149]. The content of zinc in clear human lenses is low and does not 
alter considerably with age [147]. However, at high levels, Zn2+ can react with 
H2O2 to produce toxic hydroxyl radicals that can lead to increased aggregation 
and compromise membrane permeability through oxidation of sulfhydryl groups, 
among other effects [143, 147]. Oxidative damage is discussed in greater detail 
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in the previous section. Elevated levels of zinc have also been noted in both the 
insoluble fraction of clear aged lenses as well as cataractous lenses, however, 
there is no consensus on whether this is a consequence of cataract development 
or a mediator [145, 148]. 
The long-term (330 days) effect of zinc in vitro on time-dependent 
changes in long-lived human lens proteins was followed in this experiment, and 
to the best of our knowledge, has not been examined in the past. The technique 
of QLS was utilized to detect these changes. We hypothesize that incubation of 
the water-soluble fraction of human lens proteins with Zn2+ will increase the rate 
of light scattering, compared to the untreated sample, as a result of Zn-mediated 
rise in protein-protein interactions and Zn-catalyzed oxidative damage. This 
experiment was done in conjunction with the study exploring time-dependent 
protein changes, which was discussed in Section 3.2 of this chapter. The same 
lens was used as the source of the proteins (77 y.o. female). The source of zinc 
was a solution of zinc-histidine in DI water, which was added to 3 replicate 
samples of water-soluble lens proteins at 1 mg/ml (in Phosphate Buffered Saline 
without Ca2+ and Mg2+). The concentration of Zn2+ in the lens protein samples 
was 16 µM. There were 15 QLS measurements (acquisition time of 3 s each) 
obtained for every sample at each time point. Data points in Figures 3.15 and 
3.16 represent the mean of these readings. The samples examined in Section 
3.2 represented the control or untreated set. Particle size distributions use 1 cP 
as the viscosity. Other experimental parameters match those described in 
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Section 3.2 and discussed in detail in Chapter 2. 
Compared to the untreated samples of lens proteins, the samples with 
added zinc show a significantly higher rate of increase in mean scattering 
intensity (Figure 3.15). Both sets have an initial phase where the growth rate is 
slow, with the zinc added sample displaying a slightly concave shape (76.7 
cps/day for control and 591.19 cps/day for zinc). The apparent inflection point for 
lens proteins with Zn2+ is slightly delayed (day 68), beyond which the samples 
experience sigmoidal growth kinetics. The rate of increase in scattering intensity 
was calculated to be 1159.4 cps/day, higher than the rate of increase for the 
control set (1110.8 cps/day). The variance of the mean appears to increase for 
the protein + Zn2+ case from approximately day 225 (till the end of the 
experiment). Figure 3.16 presents the change in correlation time index for the 
two samples. From this plot it is evident that there are larger sized aggregates at 
the onset in the lens protein sample with added Zn2+. We note that both sets of 
samples have an initial nucleation phase. Beyond an apparent inflection point, 
presence of zinc seems to cause a slightly highly rate of change (0.0014 ms/day) 
in the growth kinetics when compared to the control (0.0013 ms/day). Linear 
regression was applied for calculation of growth rates from the data. 
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Figure 3.15: Comparison of increase in average scattering intensity as a function of time 
between control and control with added Zn2+. Error bars represent standard deviation of 
the mean computed from measurements done on 3 replicate samples. 
 
 
 
 
Figure 3.16: Comparison of change in correlation time between control lens protein and 
control with added Zn2+. Error bars represent standard deviation of the mean computed 
from measurements done on 3 replicate samples. 
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 The increase in correlation time over the course of the experiment is 
indicative of an increase in mean particle size of the protein population. The size 
distribution plots from three time points (Figures 3.17a–c) confirm this change by 
showing a shift in distributions towards larger hydrodynamic radii over time. 
Presence of zinc causes a greater shift when compared with the control. The 
widths of the distributions also become narrower over the course of the 
experiment for both data sets. The distribution for protein+Zn2+ on day 303 shows 
the presence of a smaller peak in a lower hydrodynamic radii region. 
 
 
Figure 3.17a: Extracted particle size distributions of control and lens proteins with added 
Zn2+ at day 56 show a shift towards larger sized particles at an early stage as a result of 
zinc. 
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Figure 3.17b: Extracted particle size distributions of control and lens proteins with added 
Zn2+ at day 154 showing a shift towards larger hydrodynamic radii. 
 
 
 
Figure 3.17c: Extracted particle size distributions of control and lens proteins with added 
Zn2+ at day 303. There is even greater shift of particles towards larger sizes in the 
sample with zinc. A smaller peak appears in a lower hydrodynamic radii region 
compared with the primary peak for protein+Zn2+.  
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From data obtained in this experiment, we note that: 
i) Long-term (~ 1 year) study of a complex mixture of water-soluble human 
lens proteins with added Zn2+ as a perturbation is possible to study in an 
in vitro system. 
ii) Zinc influenced time-dependent changes were detected in lens proteins in 
vitro.  
iii) Presence of Zn2+ causes a greater increase in light scattering intensity 
and correlation time compared to control. 
iv) Two periods with different kinetics in both scattering intensity and 
correlation time were noted for both control and proteins+Zn2+. 
v) Changes in QLS signals corresponded with apparent changes in 
underlying protein distributions with respect to hydrodynamic radii. 
In this study, we evaluated the effect of perturbing the in vitro human lens 
protein model, which was examined in section 3.2, with Zn2+. The in vitro 
assessment of effects of zinc on lens proteins is important in understanding the 
metal’s role over the course of aging. Zinc’s ability to catalyze oxidation by 
producing toxic hydroxyl radicals on reacting with hydrogen peroxide, and its 
affinity to bind with α-crystallins highlight the metal’s relevance in mediating 
protein changes observed in the aging lens. In the QLS data showing change in 
scattering intensity and correlation time, the lag phase is suggestive of both 
nucleation and oligomeric elongation events, with the former being dominant. 
The slight concavity observed in the first phase of scattering intensity data 
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(Figure 3.15) for the samples with added zinc suggests the presence of pre-
existing aggregates, a possibility also attested by the larger values of correlation 
time at the onset of the experiment in the protein+Zn2+ case. This finding might 
be a result of zinc-induced stabilization of the α-crystallin oligomeric complex. 
Binding of zinc to α-crystallin promotes the protein’s chaperoning ability, an effect 
that could be caused by the increase in the surface hydrophobicity of α-crystallin 
[154] on binding with zinc. The increased reactive surface area could also lead to 
greater likelihood of protein-protein interactions and in turn, formation of high-
molecular weight species. Levels of zinc in the lens have been reported in a 
highly variable range of 60–650 µM [144], which is ~4–40 fold higher than the 
concentration used here. On the other hand, the protein concentration is ~250–
500 fold lower. Although the level of zinc in this experiment is higher in relation to 
the lens protein concentration observed in vivo, it is important to note that metal-
dependent protein changes are chronic effects that accumulate for decades. 
Hence, in order to empirically detect changes in a reasonable time frame, it is 
pragmatic to test with higher concentrations of zinc. Since no external hydrogen 
peroxide was introduced to the proteins, we do not expect metal-catalyzed 
oxidation to have a significant impact on the data. However, the high levels of 
Zn2+ added to the proteins could react with endogenous H2O2 present in the lens 
protein solution. As discussed in the preceding section, oxidative damage can 
cause increase in rates of aggregation and formation of large oligomeric 
complexes. Zinc also plays a crucial role in the aggregation of amyloid-β in 
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Alzheimer’s disease (AD), a common age-related disorder. Our group has 
previously proved the presence of Aβ in the lens of AD patients, and the affinity 
of Aβ and α-crystallin has also been demonstrated [59, 61, 146]. Moreover, in 
metallomic imaging maps of human lens tissue, zinc and Aβ co-localize in the 
cortical layers, the site of AD-related opacities (unpublished work). Thus, zinc is a 
key factor in mediating both age-dependent changes, which are observable using 
QLS in the lens. 
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3.6 Interaction with Human Amyloid-β40 
The complex molecular environment in the lens fiber cell cytoplasm 
undergoes numerous modifications with advancing age. In the preceding 
sections of this chapter, we have explored the effects of various perturbations, 
namely time, radiation, oxidative stress, and incubation with Zn2+, on water-
soluble human lens proteins in vitro, as a model system to study the age-related 
protein changes seen in vivo in the lens. Another important perturbation 
associated with the long-lived lens crystallins is the influence of the protein 
amyloid-β (Aβ) [2, 18, 59, 61, 86]. Aβ is present in the lens in low concentrations 
and gets elevated in disease states like in Alzheimer’s disease (AD) [59, 68, 69]. 
The cytosolic location of Aβ in the lens fiber cells renders it capable of 
associating with the highly concentrated mixture of crystallin proteins. This 
interaction has been confirmed by the co-localization of amyloid-β and αB-
crystallin in the supranuclear (outer cortical) opacities seen in AD lens fiber cells 
as well as in plaques present in AD brains [59, 69, 146, 153]. The high degree of 
affinity between the two proteins has been demonstrated [59, 69, 78], and the 
ability of Aβ to seed nucleation events leading to aggregation has been reported 
in AD [69]. Supranuclear Aβ-rich opacities have also been discovered in the 
lenses of Down syndrome (DS) patients [61]. In DS, there is triplication of 
chromosome 21, and on this chromosome lies the gene for Amyloid Precursor 
Protein (βAPP). The protein Aβ is a cleavage product of βAPP. Increase in APP 
gene dosage results in increased Aβ production, which ultimately manifests as 
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supranuclear cataracts similar to those seen in AD. The oligomeric complex of 
Aβ and α-crystallins is also thought to potentiate toxicity [78]. Furthermore, there 
is evidence of Aβ producing oxidative stress through a positive feedback loop 
where it induces H2O2, which in turn promotes expression of Aβ [59]. Thus, Aβ’s 
involvement in driving aggregation in the lens is an important area of study. 
The incubation of synthetic human Aβ40 (hAβ40) with the water-soluble 
fraction of human lens proteins was used as an in vitro model system to assess 
Aβ’s ability to produce protein changes in vivo. It was hypothesized that presence 
of Aβ would increase scattering of light, as determined by quasi-elastic light 
scattering (QLS), from water-soluble lens proteins due to protein aggregation. 
Water-soluble lens proteins were extracted from the left lens of a 49 y.o. female; 
the concentration of the supernatant calculated by the BCA protein assay was 16 
mg/ml. Three sets of samples were formulated: 65 µM synthetic hAβ40 in 
Phosphate Buffered Saline (PBS) (no Ca2+ or Mg2+), human lens proteins at 2.5 
mg/ml in PBS (no Ca2+ or Mg2+), and human lens proteins (2.5 mg/ml) + synthetic 
hAβ40 (65 µM) also in PBS (no Ca2+ or Mg2+). The concentration of 65 µM for 
hAβ40 was chosen based on previous research [173–175] that examined 
aggregation of hAβ40 as well as on results of pilot range-finding experiments (see 
Chapter 2 – Section 3.5). Each set consisted of 3 replicate samples. QLS 
measurements (15 readings for each sample at each time point) were obtained 
over 16 days. The acquisition time for each reading was 10 s. For size 
distribution analysis, viscosity of 1 cP was used. Details regarding formulation of 
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samples are discussed in Chapter 2. The mean of the measurements from 3 
replicate samples is presented for all sample types in Figures 3.18 and 3.19. 
Changes in average scattered light intensity (Figure 3.18) and correlation 
time (Figure 3.19) were compared among the 3 sample types. The lens proteins 
with added hAβ40 show a concave increase in scattering intensity and 
exponential growth in correlation time compared to the control, and the data 
suggests elongation of pre-formed aggregates is the dominant reaction. hAβ40 
has a known propensity to aggregate rapidly in solution, which is observed 
through the concave growth curve for intensity and a very quick exponential 
growth curve for correlation time. The average scattering intensity for untreated 
lens proteins has a distinct nucleation phase till approximately day 10, followed 
by a period of exponential growth. The correlation time for the untreated sample 
also displays a nucleation phase and in the time frame of the experiment, there 
isn’t any significant increase observed. 
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Figure 3.18: Comparison of change in average scattering intensity of lens proteins, 
human Aβ40, and lens proteins incubated with Aβ40 as a function of time. Error bars 
represent standard deviation of the mean computed from measurements done on 3 
replicate samples. 
 
Figure 3.19: Comparison of change in correlation time of lens proteins, human Aβ40, and 
lens proteins incubated with Aβ40 as a function of time. Error bars represent standard 
deviation of the mean computed from measurements done on 3 replicate samples. 
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In Figures 3.20a–c, particle size distributions of the three samples are 
compared at different time points along the course of the experiment (0 hr., 17 
hr., and 53 hr. respectively). The fast rate of aggregation of amyloid-β is reflected 
in the shift in size distribution and subsequent precipitation within 3 days of 
incubation. The increase in width of the distribution suggests a rise in 
polydispersity. Lens proteins with added hAβ40 tend to aggregate at a greater 
rate compared to the control as noted in the size distributions. In Figure 3.20d 
(88 hr.), the peaks for control + hAβ40 have shifted considerably towards larger 
hydrodynamic radii. The shape of the distribution for control + hAβ40 presents 
interesting changes. At 0 hr. there is significant overlap between control and 
control + hAβ40; by 17 hrs. there is presence of a second lower molecular weight 
peak in control + hAβ40 but not seen in control and the major peaks for the 2 
samples are overlapped. The distribution plots at 53 hrs. and 88 hrs. suggest an 
increase in particle sizes of the protein population as well as in polydispersity for 
control + hAβ40.  
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Figure 3.20a: Particle size distributions at the onset (0 hr) of the experiment. Significant 
overlap noted for control and control + hAβ40.  
 
 
 
Figure 3.20b: Particle size distributions at 17 hrs. hAβ40 shows increase in mean particle 
hydrodynamic radius, while the distribution for control + hAβ40 suggests more particles in 
the larger size range. 
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Figure 3.20c: Particle size distributions at 53 hrs. hAβ40 has formed really large 
aggregates and precipitates out soon after. The shift in the distribution of the sample 
with added hAβ40 signifies the increase in particle sizes compared to control. 
 
 
 
Figure 3.20d: Particle size distributions at 88 hrs. Control + hAβ40 sample shows a 
marked increase in hydrodynamic radius compared to control. 
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A summary of the major results obtained in this study is as follows: 
i) Aβ-mediated protein changes, observed in vivo, can be studied in vitro 
through incubation of synthetic hAβ40 with water-soluble human lens 
proteins. 
ii) QLS allows detection of Aβ-dependent modifications to lens proteins. 
iii) Aggregation of hAB40 can be monitored in vitro using QLS. 
iv) Presence of Aβ potentiates aggregation of human lens proteins. 
v) Particle size distributions suggest an increase in high molecular weight 
protein species as a function of time due to presence of hAβ40. 
This study evaluated the effect of protein-protein interactions as a 
perturbation to the age-related changes observed in the lens through an in vitro 
model. Specifically, we analyzed the influence of Aβ in enhancing aggregation 
reactions by incubating a synthetic form (human Aβ40) with water-soluble human 
lens proteins, and observing changes via QLS. The affinity between Aβ and α-
crystallins has been previously established. We confirmed this through the 
average scattering intensity and correlation time data, which suggest fast 
reaction kinetics in the association between the two proteins. Growth curves 
obtained for intensity and correlation time were reflective of pre-seeded 
aggregation. The lag phase observed in data from the control is likely due to 
primary and secondary nucleation events. Aggregation of Aβ is widely studied as 
a consequence of its relevance in Alzheimer’s disease. Here, the data collected 
for hAβ40 are typical of oligomer elongation events with large aggregates being 
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formed that end up precipitating out of solution. Size distributions extracted from 
autocorrelation functions signified an increase in high-molecular weight species 
of lens crystallins as a consequence of aggregation induced through interaction 
with Aβ. Although there wasn’t any hydrogen peroxide introduced in the 
experimental conditions, Aβ-mediated oxidative stress could also have been a 
factor in aggregation due to its reaction with any endogenous H2O2 in the lens 
protein solution. 
 
As we have noted in the preceding sections of this chapter, investigation 
of protein changes is effective in the lens due to the absence of protein turnover. 
The lens accrues damage to its constituent long-lived crystallin proteins with 
advancing age and influence of perturbations, such as Aβ-driven aggregation. 
Increased deposition of protein aggregates is characteristic to a number of 
diseases, with Aβ being one of the major proteins involved in the pathogenesis of 
AD. In Chapter 4, we demonstrate the application of QLS for detection of early 
stage Aβ-related protein changes in the lenses of Down syndrome subjects. 
In this chapter, the behavior of long-lived human lens proteins over time 
and on exposure to specific physiologically relevant perturbations was examined. 
The changes that beset proteins in the lens, chiefly crystallins, were assessed in 
in vitro model systems using the sensitive technique of quasi-elastic light 
scattering as well as by protein gel electrophoresis and transmission electron 
microscopy. Lens proteins showed time-dependent changes characteristic of 
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aggregation and protein-protein interactions. Post exposure to x-ray radiation, a 
shift towards higher molecular weight aggregates was observed in the treated 
protein samples when compared to the untreated control. Radiation has been 
known to promote aggregation by inducing cross-linking, fragmentation, and 
conformational changes to protein structure. In the accelerated aging model 
based on metal-catalyzed oxidation, the proteins displayed a tendency to form 
large oligomeric aggregates at a much faster rate than the control. This can 
possibly be attributed to oxidative damage resulting in increased misfolding, loss 
of function, and degradation. The effect of Zn2+ on lens proteins was also to 
significantly increase the rate of scattering intensity, correlation time, and cause 
the particle size distribution to progress towards larger sizes. By increasing the 
chaperoning activity of α-crystallin, Zn2+ causes enhancement of protein-protein 
interactions, which in turn leads to proliferation of oligomeric species. Incubation 
of the lens proteins with human Aβ40, a major component of amyloid deposits 
found in the lens and brain of Alzheimer’s disease and Down syndrome patients, 
produced rapid changes in particle size and scattering intensity. A primary 
reason for this could be the high-degree of affinity between Aβ and α-crystallin 
also observed through their co-localization in neural plaques and supranuclear 
lens opacities found in AD and DS patients. 
The studies discussed in this chapter show that QLS, combined with size 
distribution analysis, can be applied to monitor and detect early molecular events 
in a complex mixture of proteins. QLS provides repeatable data (as noted by the 
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low variance in multiple measurements on multiple replicates of the same 
sample), is sensitive, and doesn’t involve destruction of the sample or excessive 
manipulation of samples, which can lead to artifacts. Size distribution analysis, 
using DYNALS (for more information see Chapter 2 and 5), is a powerful tool to 
extract underlying particle distributions from the autocorrelation functions of 
fluctuations in light intensity. However, there are some caveats in these 
techniques that should be considered while interpreting the data. For instance, 
QLS, as applied here, cannot differentiate between shape- and size-related 
changes. The inversion problem that computes size distribution from the 
autocorrelation function is strongly influenced by error in the data. This can affect 
the width of the calculated size distribution, and in turn influence the inference of 
polydispersity. Long acquisition times, clean cuvettes, and multiple 
measurements are useful in mitigating this problem. 
In summary, long-lived water-soluble human lens proteins provide a 
competent in vitro model system to study changes in the protein environment due 
to perturbations of time, radiation, oxidative stress, influence of metals such as 
Zn2+, and interaction with other proteins such as amyloid-β, using the technique 
of QLS.  
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Chapter 4 
In Vivo Assessment of Age-Related Protein Changes in the Human Lens 
 
4.1 Age-Related Protein Changes in the Humans Lens 
 
Aging is an inhomogeneous process, characterized by large inter- and 
intra- species variability [41, 155]. Over the course of aging of the body, there is 
loss of functionality of cellular constituents and degradation of systems that 
protect cells against various forms of stress [8, 13, 20, 38, 43, 57]. One of the 
components that experience significant changes over time is the proteome, the 
entire set of proteins expressed in a cell or organism, at a given time [156]. 
Proteins undergo a variety of post-translational modifications (PTM) as a function 
of time, which can affect their normal functional roles [32, 33, 46, 157]. PTM’s in 
specific proteins lead to pathogenic protein aggregation and trigger disease 
states such as Alzheimer’s disease (AD), Parkinson’s disease, pulmonary 
fibrosis, age-related cataracts, amongst others [46, 57, 59–61, 133]. Moreover, 
molecular changes at the level of proteins may precede the observable disease 
[60, 88, 130].  
Long-lived proteins, such as dentine, elastin, collagen, and lens crystallins 
accumulate PTM’s and record the history of molecular aging. Furthermore, there 
is a disparity between chronological age and biological or molecular age due to 
observed differences in lifespan, rate of aging, and change in age-dependent 
biological parameters within the same species, which makes the former an 
ineffective index for prediction of the onset of a disorder [3, 4, 155, 158]. This 
  
110 
formulation has led to the search for molecular biomarkers of aging, a term that 
has been defined as a ‘biological parameter of an organism that either alone or in 
some multivariate composite will better predict functional capability at some late 
age, than will chronological age’ [159].  
Within the spectrum of long-lived proteins in the human body, the lens 
crystallins are particularly significant. This evolutionarily conserved family of 
proteins, in the lens fiber cell cytoplasm, is amongst the longest-lived proteins, 
and undergoes extensive post-translational modifications with age [13, 32, 33, 
41]. As a consequence of the evolutionary development and functional 
specialization of the lens, there is absence of protein turnover in the lens fiber 
cells over the human lifespan [8, 13, 41], which leads to preservation of protein 
modifications. Because the lens is optically accessible from the periphery and 
displays age-dependent spatial organization of the fiber cells [12, 17, 19, 35], this 
tissue provides an ideal target for assessment of cumulative changes over the 
course of aging (Figure 4.1). 
There are a number of mechanisms that protect lens proteins and delay 
damage caused by aging, disease, and environmental exposures (e.g., exposure 
to radiation, oxidative stress, and toxins). While it may take decades for the end 
stage of modifications to manifest, for instance, as cataracts, there are many 
age- and disease-dependent changes at the molecular level that occur while the 
lens is transparent [41]. Previous studies have also shown a correlation between 
ocular disorders and systemic and neurological diseases [4, 5, 11, 160, 161]. 
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These considerations suggest that the ability to quantitatively detect early 
changes in the lens proteins affords potential as a biomarker of molecular aging. 
 
 
 
Figure 4.1: The human lens is an ideal system to assess molecular aging. Major 
structures and regions are marked and the cross-section of the lens fiber cells illustrates 
the organization that helps provide transparency. 
 
Characterized by a life-long morphogenetic process that slows as a 
function of age, human lens development starts with the thickening of the surface 
ectoderm to generate the lens placode. This is followed by generation of the lens 
vesicle [8]. Further growth takes place with differentiation and elongation of 
anterior cuboidal epithelial cells at the equator, to form long fiber cells that 
organize into a tightly packed quasi-hexagonal array (Figure 4.1). As the lens 
ages, new layers of fiber cells overlay the existing ones, with the central nuclear 
region being composed of cells of embryonic origin [41]. Thus, it is possible to 
follow the spatially dependent developmental history of the lens from the nucleus 
to the cortex [23] (see Chapter 1 for more details on growth of the human lens).  
The primary function of the human lens is to transmit light and focus an 
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image on the retina. The lens evolution has sculpted the lens structure to 
optimize functionality in both domains (i.e., transparency and accommodation). 
Within the fiber cells, the long-lived crystallin proteins are present at a very high 
concentration (300–450 mg/ml) and remain extant for life [20, 23, 41, 42]. There 
are three primary families of crystallins - α, β, and γ crystallins, and multiple 
subspecies of the three. As a result of age-related modifications, the diversity of 
crystallin proteoforms increases. The high concentration of the crystallins in the 
cytosol of the lens fiber cells results in the required refractive index, and 
variations in distribution and concentration of the different species lead to a 
gradual increase in refractive index from the cortex to the core. This effectively 
acts as a biological gradient-index (GRIN) optical element that reduces spherical 
aberration. Moreover, the packed organization of the fiber cells prevents large 
fluctuations in the refractive index. Previous research has shown that absorption 
of light is negligible in the lens, as normal lens components lack absorption 
bands in the visible range, and scattering of light due to the cell membrane 
components is minimal [23]. Scattering from the cytoplasmic contents of the lens 
fiber cells is reduced due to the loss of their nuclei and cellular machinery [19, 
23, 26, 35]. In an environment lacking organelles, the transparency and observed 
light scattering can be explained by the fact that the cytoplasm displays a liquid-
like organization, characterized by short-range order, with the protein 
components approximated as homogeneous hard spheres [23]. 
In Chapter 3, the water-soluble fraction of homogenized human lenses 
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was examined in vitro as a model system for age-dependent changes in the lens 
in vivo. The effects of physiologically relevant perturbations (time, x-irradiation, 
oxidative stress, incubation with Zn2+, and amyloid-β protein potentiated 
aggregation) on the molecular dynamics of the long-lived lens proteins were 
monitored using quasi-elastic light scattering (QLS). Our results denoted that 
early-stage alterations in the protein environment were detectable by QLS. 
Consequently, the next step was to test the capability of QLS to detect protein 
changes in vivo. Age-related protein changes have been previously reported in 
lenses of animals such as mice, meadow voles, and rabbits, among others, both 
in vitro and in vivo [99, 101, 102, 162–164]. 
In this section, we demonstrate the application of QLS for assessment of 
age-dependent changes in the human lens in vivo. We hypothesize that 
accumulation of age-related protein modifications leading to aggregation and 
disruption of lens protein order will produce increased light scattering in the lens. 
To test this hypothesis, we conducted an in vivo study on humans. Our QLS 
instrument received FDA approval as a non-significant risk investigational device 
for a cross-sectional clinical study at Boston Children’s Hospital. Thirty-four 
human subjects, aged 5 to 61 years of age (18 males and 16 females) were 
tested for this study. None of the subjects, at the time of the examination, were 
noted to have visible opacities or frank cataracts. The subject’s pupil was dilated 
with Phenylephrine and the accommodative capacity of the lens was abolished 
using Tropicamide. QLS measurements were performed in the nuclear region of 
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the lens, the site of the oldest proteins, of the right eye (Figure 4.1). Data from 
each patient was acquired in 3 scans, with each scan constituting of 5 replicates. 
Each replicate comprised of an acquisition time of 0.22 s. A viscosity of 5.74 cP 
was used for computing size distributions. Technical details regarding the study 
design are provided in Chapter 2. 
In vivo performance validation of the QLS device was performed by 
comparing 5 data sets obtained from the same control subject within a time span 
of 20 minutes. Each data set consisted of 15 replicates and measurements within 
that set took approximately 1 min to complete. The subject was given 2–3 min to 
rest between the sets to mitigate fatigue. The scattering intensity and correlation 
time from this analysis is presented in Figures 4.2 and 4.3, respectively. The 
mean values for both indices were not statistically significant within the 5 data 
sets (p-value for scattering intensity differences = 1.0; p-value for correlation time 
differences = 1.0).  
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Figure 4.2: Average scattering intensity measurements obtained from a 15 y.o. male 
subject. Error bars represent standard error of the mean. Horizontal dashed lines signify 
95% confidence intervals. 
 
 
 
 
Figure 4.3: Correlation time computed from measurements obtained from a 15 y.o. male 
subject. Error bars represent standard error of the mean. Horizontal dashed lines signify 
95% confidence intervals. 
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The results from this clinical study showed that an increase in age results 
in slower decay of the scattering intensity autocorrelation function (ACF), which 
signifies slower diffusion rates in the underlying particle distribution. The diffusion 
coefficient and particle size are inversely related. Figure 4.4 shows 
representative intensity autocorrelation functions for three subjects of different 
ages (12 y.o. male, 30 y.o. female, and 53 y.o. male) and the corresponding 
extracted size distributions are presented in Figure 4.5. The rate of decay of the 
correlation function is indicative of the mean diffusivity of scattering particles in 
the sample region. The observed ACF’s reveal at least two distinct slopes, a 
finding consistent with the high polydispersity of scatterers in the human lens. 
Hydrodynamic radii distributions were calculated from the ACF’s (in Figure 4.4) 
are presented in Figure 4.5. Each distribution has two major peaks. The size 
distributions shift towards larger hydrodynamic radii with an increase in age. We 
also noted a decrease in the hydrodynamic radii of the smaller peak, which could 
potentially be a consequence of conversion of low-molecular weight species into 
high-molecular weight aggregates [15, 29, 30, 49].  
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Figure 4.4: Examples of ACF’s for different ages. The correlation function decay rate 
increases with age. M12 – 12 y.o. male; F30 – 30 y.o. female; M53 – 53 y.o. male. 
 
 
 
 
Figure 4.5: Extracted particle size distributions for the same subjects as in Figure 4.4. 
Age results in a shift of the protein population towards larger hydrodynamic radii. M12 – 
12 y.o. male; F30 – 30 y.o. female; M53 – 53 y.o. male. 
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The correlation of changes in proteins with age is also of significance 
when plotted as a function of age (Figures 4.6 and 4.7). Scattering intensity 
(Figure 4.6) has an exponential dependence (correlation coefficient for 
exponential fit = 0.98) with increasing age, likely due to the various modifications 
that happen to the lens proteins. These alterations have been known to induce 
aggregation of proteins into larger oligomers and gradual insolubilization of 
soluble crystallins. Values of correlation times (Figure 4.7) obtained from the 
study cohort demonstrate linear dependence with age (correlation coefficient of 
linear fit = 096). This finding is suggestive of an increase in mean particle size of 
the scatterers in the nucleus of the lens as a function of age. The three subjects 
discussed in Figures 4.4 and 4.5 are marked on the curves in Figures 4.6 and 
4.7. 
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Figure 4.6: Increase in light scattering intensity as a function of age. Data collected from 
nuclear region of the lens, 18male 16female subjects. Exponential fit with R2 = 0.98 
describes change in signal. Error bars represent standard deviation from the mean 
calculated on measurements obtained from an individual. 
 
  
 
 
Figure 4.7: Change in correlation time observed with increase in age. Linear fit has R2 = 
0.96. Error bars represent standard deviation from the mean calculated on 
measurements obtained from an individual. 
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The major findings in this study can be summarized as follows: 
i) Age-related molecular changes in the human lens are detectable by QLS 
in vivo. 
ii) Our QLS device provides repeatable in vivo measurements as observed 
from multiple measurement sets from the same subject. 
iii) ACF’s obtained from the human lens reflects the high degree of 
polydispersity of proteins in the nuclear region. 
iv) Extracted particle size distributions of the lens protein population 
increased towards larger hydrodynamic radii with advancing age. 
v) Age-dependent changes in scattered light intensity and correlation time 
were observed as a function of increasing age. 
The in vivo investigation of age-related changes to lens proteins using 
QLS was the subject of this study. Age-dependent changes in the lens have 
been previously studied in vivo using imaging techniques (e.g. Slit-Lamp 
Biomicroscopy, Optical Coherence Tomography, Scheimpflug Imaging). These 
techniques detect static scattering and are useful for observation of end stages of 
the aggregation process – cataracts. However, in order to assess early changes 
in molecular events, a more sensitive technique that detects dynamic molecular 
behavior like quasi-elastic light scattering needs to be used. QLS can detect the 
effect of changes in protein concentration, conformation, and size at a nanometer 
scale, long before onset of static scattering defects, such as frank cataracts. The 
results in this section demonstrate the use of QLS in studying age-dependent 
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changes in vivo in a cohort of healthy subjects without any visible cataracts. 
When compared to in vitro results, the age-dependence of scattering intensity 
and correlation time in vivo was noted to be functionally similar (see Figures 3.4 
and 3.5 in Chapter 3). In the particle size distributions extracted from the ACF’s, 
a shift towards larger hydrodynamic radii was observed as a function of 
increasing age. These modulations of protein behavior can be attributed to the 
gradual decline of the lens’ protective systems to combat stresses associated 
with aging. Due to oxidation, cross-linking, glycation, and other post-translational 
modifications, proteins develop a greater propensity to aggregate. There is also 
increased unfolding associated with the PTM’s, which leads to enhanced 
activation of chaperone proteins such as α-crystallin. Since there is no protein 
synthesis in the mature fiber cells, the finite stock of soluble α-crystallin reduces, 
while there is an increase in its bound aggregate form. Previous studies have 
reported negligible levels of α-crystallins in the water-soluble fraction obtained 
from aged lenses [12, 13, 28, 30, 32]. Moreover, the insoluble fractions from 
these aged lenses, and age-related nuclear cataracts have been shown to 
contain a high percentage of α-crystallins [13]. The decrease in soluble protein 
forms also causes stiffening of the fiber cells, which results in increased 
mechanical stress and compromises the transport system between cells. With 
inhibited movement of molecules like anti-oxidants from the cortex to the deeper 
layers, there is effectively a barrier created that promotes and accumulates 
damage due to oxidation and other modifications.  
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Assessment of lens proteins in vivo in this cohort of healthy individuals 
using the non-invasive and sensitive technique of QLS represents a preliminary 
effort in establishing a baseline quantitative biomarker of molecular aging. As a 
result of the correlation between changes seen in the lens and systemic 
expression of certain disorders, the QLS-based biomarker could potentially be 
utilized, and combined with other biologically relevant indices, to classify 
individuals at a high-risk of developing certain diseases. The protein changes 
seen as a consequence of aging are exacerbated in conditions featuring 
pathogenic protein aggregation, such as amyloid-β (Aβ) aggregation in 
Alzheimer’s disease. In the next section, we explore the effect of Aβ-potentiated 
protein changes in lenses of Down syndrome (DS) subjects in vivo. In DS, there 
is proliferation of Aβ protein that manifests in the lens as supranuclear opacities 
similar to those seen in AD. The ability of QLS to detect lens protein changes is 
demonstrated in two clinical studies comparing DS and controls. 
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4.2 Alzheimer’s Disease-Related Lens Protein Changes in Down 
Syndrome – The Longwood Cohort 
Down Syndrome (DS) is the leading genetic cause of intellectual disability 
in humans. It is the most common chromosomal disorder affecting approximately 
1 in 700–1000 births [61, 165]. Due to advancements made in the treatment of 
cardiovascular diseases, fatality in DS has decreased appreciably, with 
individuals living longer than ever. Between 1990 and 2013, the number of 
deaths was reduced from 43,000 to 36,000. DS is characterized by the abnormal 
deposition of the protein amyloid-β (Aβ) in the brain and the lens, pathology that 
is similar to that seen in Alzheimer’s disease (AD) [59, 61]. The reason for this 
phenotype is the extra copy of the Amyloid Precursor Protein (APP) gene present 
on chromosome 21 due to trisomic aneuploidy [61]. DS is defined by the trisomy 
of chromosome 21, and Aβ is a cleavage product of APP. As a result of the 
increased APP gene dosage, there is overexpression of Aβ, which causes 
accumulation of the peptide in the brain and the lens [59, 61, 70, 71, 88, 165, 
166]. Elevated Aβ protein aggregation manifests in the brain as plaques and in 
the lens as supranuclear cataracts [61]. The supranuclear region corresponds to 
the deep cortex of the lens (Figure 4.1). While DS and AD share similar 
molecular pathology, the rate of AD-linked Aβ pathology in lens and brain is 
accelerated [61, 87]. Additionally, the probability of onset of dementia is very high 
in DS subjects in the 30’s [70]. Development of early-onset AD neuropathology in 
DS is an invariant feature of DS cases over the age of 30 but may emerge as 
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early as in the first decade of life [61]. Similarly, the opacities that are seen in DS 
lenses are observed very early in life [61]. Following the onset of pathology, there 
are progressive age-dependent changes observed in both the brain and the lens. 
Thus, DS represents an early-onset, 100% penetrant, model of AD, and permits 
monitoring of progressive AD-related changes. This is particularly beneficial 
because familial forms of early-onset AD are relatively rare, and due to a lack of 
effective diagnosis methods, detection of AD pathology isn’t possible until late in 
the stage of the disease.  
The lens of the eye presents a promising target for early detection of AD-
related protein changes. Abnormalities observed in the lenses of DS patients in 
the form of Aβ-rich supranuclear opacities have not been observed in healthy 
controls or in any other non-AD age-related neurodegenerative diseases [59]. 
These AD-linked Aβ lens opacities are biochemically, anatomically, 
phenotypically, and ultrastructurally distinct from age-related cataracts [61]. The 
major constituents of the lens fiber cells are crystallin proteins. The class of α-
crystallins is distinguished by its established interaction with Aβ, which is also 
noted to be endogenously generated in the lens fiber cells [61]. The interaction of 
Aβ and α-crystallin potentiates toxicity by inducing aggregation [78]. The 
presence of αB-crystallin in neuritic plaques found in AD brain tissue and co-
localization of αB-crystallin and Aβ as cytosolic oligomeric aggregates in the 
supranuclear fiber cells underscore the involvement of both proteins in 
pathogenic aggregation. Due to lack of protein turnover in the lens fiber cells, it 
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has also been hypothesized that AD-linked, Aβ lens pathology may precede 
corresponding Aβ neuropathology [61]. Furthermore, the early commencement of 
lens opacities compared to neuropathology has been demonstrated in AD within 
a large community-based cohort (Framingham Eye Study) [60]. The lens is 
optically accessible and alterations in its cellular environment are preserved. 
Moreover, as demonstrated through in vitro experiments (Chapter 3) and the in 
vivo assessment of molecular aging (Section 4.1), QLS has proved to be an 
effective and sensitive tool for detection of early stage molecular changes in 
human lens proteins. 
In this study, we evaluated protein changes mediated by AD-related 
pathology in vivo in the lenses of DS subjects and compared the findings with 
observations obtained from age-matched controls. We hypothesized that 
overexpression of Aβ in DS would cause modifications to the lens protein 
environment by elevating protein aggregation. To monitor these changes, our 
QLS instrument was employed in two cross-sectional clinical studies at Boston 
Children’s Hospital (BCH). The first study was conducted at the Boston 
Longwood Site of BCH, and will be the subject of discussion in this section. The 
second study involved a separate cohort population, and was performed at the 
BCH Satellite Site in Peabody, MA to test and validate inferences drawn from the 
Longwood cohort. Measurements were obtained from the supranuclear region of 
the lens (Figure 4.1) in both studies, corresponding to the location of amyloid 
accumulation as reported previously [61]. 18 Control (11male, 7female, mean 
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age: 15.5 y.o. ± 2.1) and 8 DS (5male, 3female, mean age: 13.6 y.o. ± 2.1) 
subjects were included in the Longwood Study cohort. Each measurement 
comprised of an acquisition time of 0.22 s. A viscosity of 5.74 cP was used for 
computing size distributions [94]. In order to preclude any age-dependent effect, 
only subjects aged between 10–20 years were examined. The progression of 
ocular abnormalities is so rapid in DS that a large percentage of individuals in 
their second or third decade of life develop visible opacities, and in many cases, 
frank cataracts [61]. Evaluation in this range was also linked to our hypothesis 
that DS pathology in the lens precedes that in the brain. Furthermore, QLS is a 
more sensitive technique compared to imaging methods, which is the standard 
approach and has detected AD-pathology in DS brains only late in the third 
decade of life. 
The representative autocorrelation functions (ACF) of scattered light 
intensity collected using QLS show a difference in the rate of decay between a 
DS subject and a comparably aged normal Control (Figure 4.8). The rate of 
decay is inversely proportional to the diffusion coefficient and this Figure 4.8 
would suggest that the mean diffusivity for the DS case is greater. Using the non-
negative truncated singular value decomposition method, the size distributions 
are extracted from the ACFs (Figure 4.9), and signify a shift towards larger 
particle sizes for the Control individuals. Thus, the analysis of correlation of 
scattered light fluctuations is able to utilize the dynamics of the lens’ molecular 
constituents to distinguish between the two groups. In contrast, measurements of 
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the average scattered light intensity do not show a statistically significant 
difference between Control and DS (Figures 4.10 and 4.11).  
In Figure 4.10, we note that age does not produce any significant change 
in the 10–20 year range. For both Control and DS, the dependence of intensity 
on age is non-significant as computed by rank correlation (p-value = 0.66 for 
Control and 0.82 for DS). The boxplot representation (Figure 4.11) provides 
another visual for comparing the average intensity and the distribution of data for 
the two groups. Data points are marked outliers when they are ≥1.5*σ. The 
Control group had one outlier data value. A one-factor ANOVA computed at a 
significance level of α = 0.05 produced a p-value of 0.12, confirming the lack of 
statistical significance in scattering intensity between Control and DS.  
 
 
Figure 4.8: Difference in the rate of decay of ACF’s between representative Control and 
DS subjects. Black curve fits were generated during the process of finding the optimal 
solution for the particle size distribution. M13 – 13 y.o. male control and F15 – 15 y.o. 
female DS subject. 
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Figure 4.9: Particle size distributions extracted from representative ACF’s show a shift 
towards larger sizes for Control subjects. F16 – 16 y.o. female control, M13 – 13 y.o. 
male control, F15 – 15 y.o. female DS subject, and M16 – 16 y.o. male DS subject. 
 
 
 
Figure 4.10: In the age-range of 10–20 years, there is no age-dependent effect on 
average scatting intensity. Error bars represent standard deviation from the mean.  
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Figure 4.11: Box plot representation of scattering intensity between the two groups. 
Mean scattering intensity (black bar) is not statistically significant between the groups (p-
value = 0.12). 
 
 
The usefulness of QLS is illustrated through the plots of the correlation 
time index (Figures 4.12 and 4.13). While measurements of average intensity 
(static scattering) didn’t show a significant difference between the two groups, 
dynamic light scattering was able to distinguish Control from DS in a statistically 
significant manner. The correlation times were computed from ACF’s for the two 
groups. As discussed in Chapter 2 – Section 1, the calculation of correlation time 
does not involve any variables of viscosity or temperature. Correlation time 
provides an easy-to-understand metric describing the mean dynamics of the 
scattering system, and the size distribution extracted from the ACF enables an 
added level of interpretation using distribution of the scatterers. Similar to 
intensity, age does not produce any statistically significant change in the 
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behavior of correlation time in either of the groups (Figure 4.12). The p-value 
from rank correlation analysis between age and correlation time was found to be 
0.99 and 0.46 for Control and DS respectively. In Figure 4.13, the boxplots for 
correlation time are depicted. Data points are marked outliers when they are 
≥1.5*σ. The difference in mean value of correlation time between Control and DS 
groups is statistically significant. The one-factor ANOVA analysis at a 
significance level of testing of α = 0.05 resulted in a p-value of 0.004. 
 
 
 
Figure 4.12: In the 10-20 year range, age and correlation time are uncorrelated. Error 
bars signify standard deviation from the mean. 
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Figure 4.13: Boxplot representation of the correlation time distribution and mean (black 
horizontal bar) for the two groups. The mean correlation time between Control and Down 
syndrome is statistically significant (p-value = 4e-3). 
 
 
The major findings in this study were: 
i) QLS can be applied to detect AD-related protein changes in the lenses of 
DS subjects. 
ii) No age-dependent change is observed in the 10–20 year range for 
Control and DS subjects. 
iii) Average scattering intensity is unable to detect statistically significant 
differences between Control and DS. 
iv) QLS is able to differentiate Control and DS groups aged 10–20 years with 
a statistically significant difference in means of correlation time. 
v) Particle size distributions extracted from the ACF’s suggest a shift towards 
larger hydrodynamic radii for Control subjects. 
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This clinical study was the first instance of the application of QLS to detect 
AD-related protein changes in DS lenses in vivo. Moreover, this is the first 
instance where a statistically significant difference was found in vivo between 
Control and DS subjects in the 10–20 year range. Through the results of this 
study, the consequence of accelerated Aβ pathology on the molecular 
environment of DS lens fiber cells was detected. Aβ plays a critical role in 
potentiating aggregation of proteins [59, 63, 69, 167]. As discussed in Chapter 3, 
and as reported in previous studies, Aβ has high affinity for α-crystallin causing 
an increase in formation of high molecular weight aggregates [59, 61, 77, 168]. 
Aβ also participates in metal-catalyzed reactions that produce hydrogen 
peroxide, which in turn induces expression of Aβ resulting in a positive feedback 
cycle [167]. In both Alzheimer’s disease and DS, there is overexpression of Aβ 
resulting in accumulation as Aβ-containing aggregates in the brain and lens. The 
development of AD-related lens abnormalities has been found to precede 
neuropathology in the case of AD. For DS, a similar hypothesis has been 
suggested. The presence of increased levels of soluble Aβ from an early age in 
the DS brain further strengthens the hypothesis that observable plaques are end-
state aggregation products that are generated by smaller oligomeric species. 
In the cohort tested, a statistically significant difference in correlation time 
was observed. The Control group had a mean correlation time of 7.64 ms ± 4.33 
compared to the DS group’s 5.6 ms ± 1.5. The decrease in correlation time for 
DS subjects may appear to be counter-intuitive considering the increased 
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aggregation and protein deposition events. This could be explained by a change 
in local viscosity in the lens fiber cells caused by accumulation of large protein 
oligomers. It is probable that the region around the dense aggregates could have 
reduced viscosity. As a result the extracted size distributions would get affected 
due to the increased diffusivity of particles in the regions of low viscosity. In DS, 
the rate of protein association phenomena is advanced compared to the gradual 
process over age. The lens is not fully able to mitigate the damage brought about 
functionally and structurally as a product of rapid protein deposition. An important 
and relevant effect of aggregation and oxidative stress, as a result of Aβ 
aggregation, is the disruption of membrane integrity and cell-cell connections. 
Protein oligomers have been shown to bind to membrane proteins compromising 
their functionality. Since localization of the insults is in the supranuclear region, 
another possible explanation of the lower correlation time values that was noted 
in DS could be based on this area’s proximity to the metabolically active 
outermost cortical layers. For example, the constituents for synthesis of the Major 
Intrinsic Protein (MIP26), which represents 50% of all membrane proteins, is 
confined to the superficial 5–10% of the lens. Jeopardizing MIP26’s synthesis or 
function could potentially lead to local structural damage. This could in turn affect 
ionic gradients and result in formation of water vacuoles or abnormal inter-
cellular molecular movements. There is also no new protein synthesized in 
mature lens fiber cells. Hence local clustering could cause a reduction in 
viscosity in the vicinity of the protein oligomers. 
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No significant change was seen for the measure of mean scattering 
intensity between Control and Down syndrome subjects. This is likely due to this 
index being largely unaffected by the underlying molecular dynamics. One of the 
limitations of this study was the small sample size. In an effort to replicate these 
findings and further confirm our inferences, a second clinical study was 
undertaken at the Peabody Site of Boston Children’s Hospital. Results are 
discussed in the following section. 
  
  
135 
4.3 Alzheimer’s Disease-Related Lens Protein Changes in Down 
Syndrome – The Peabody Cohort 
A second clinical study was undertaken using the same QLS instrument at 
the Peabody location of Boston Children’s Hospital in order to validate findings 
from the Longwood study. Measurement parameters were the same (acquisition 
time of 0.22 s for each measurement from the supranuclear region). The cohort 
used for this study was larger and in the same age range of 10–20 years: 16 
Control subjects (6male, 10female, mean age: 12.44 y.o. ± 2.2) and 15 DS 
subjects (9male, 6female, mean age: 13.88 y.o. ± 3.35). Conclusions derived 
from the Longwood study were verified in these results. The ACF’s show a 
difference in the rate of decay that is also reflected in the subsequent Figures of 
correlation times. Representative autocorrelation functions are presented in 
Figure 4.14. The two example subjects are also featured in Figure 4.15 along 
with another subject from each group. The particle size distributions are able to 
distinguish Controls from DS individuals. A viscosity of 5.74 cP was used in the 
computation.  
The findings on differences in scattering intensity (Figures 4.16 and 4.17) 
between Control and DS were similar to those obtained at Longwood. Through 
rank correlation analysis, age was determined to not be a factor for DS (p-value = 
0.007); however, there was a significant p-value obtained for the correlation 
between age and intensity in Controls (p-value = 9.1e-4). There was also no 
statistical significance derived on comparison of the means of scattering 
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intensity. The p-value calculated from a one-factor ANOVA analysis was 0.09. In 
the boxplots, data points are marked outliers when they are ≥1.5*σ. While there 
was an age-related effect on scattering intensity for the Control group, the 
absence of a statistically significant difference between Control and DS suggests 
that the age-related correlation for the former is not a factor. 
 
 
 
Figure 4.14: Comparison of example ACF’s of Control and DS subjects. Black curve fits 
were generated during the process of finding the optimal solution for the particle size 
distribution. M17 – 17 y.o. male Control and F16 – 16 y.o. female DS subject. 
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Figure 4.15: Particle size distributions extracted from representative ACF’s illustrate shift 
towards larger sizes for Control subjects. F11 – 11 y.o. Control, M17 – 17 y.o. male 
Control, M12 – 12 y.o. DS subject, and F16 – 16 y.o. female DS subject 
 
 
 
Figure 4.16: Age is not a factor in the 10–20 year range on the behavior of average 
scattering intensity for DS, but is calculated to be significant for Control. Error bars 
represent standard deviation from the mean. 
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Figure 4.17: The boxplot representation reaffirms the lack of significance (p-value = 
0.09) in scattering intensity between the groups. Black horizontal bar denotes mean 
value. 
 
 
Data from this cohort also showed a statistically significant difference 
between the means of correlation time for the Control and DS groups as seen in 
the Longwood study. Figures 4.18 and 4.19 present the comparison in the mean 
correlation time index. The p-value obtained was 0.02. In the boxplots, data 
points are marked outliers when they are ≥1.5*σ. Both Control and DS had one 
outlier each. Similar to the other data sets, the age range of 10–20 years did not 
produce significant differences in correlation times for Control and DS groups (p-
value = 0.41 and 0.40 for Control and DS respectively). 
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Figure 4.18: Correlation times for subjects in the two groups. No age-dependent effect 
seen. Error bars represent standard deviation from the mean. 
 
 
Figure 4.19: Statistically significant difference observed between the means of 
correlation time for Control and DS groups. Black bar shows mean of the group (p-value 
= 0.02). Outliers are represented by the diamond symbols outside of the maximum and 
minimum bars (each group has 1 outlier). 
 
 
One of the criterions for exclusion from both the Longwood and Peabody 
studies was the degree of observed lens opacity. This was a concern for the 
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Down syndrome group due to the expedited onset of supranuclear lens 
pathology. Since the goal of this research is early detection of Aβ-dependent 
changes in the lens, prior to development of mature cataracts, having large 
visible opacities contradicts the logic of the study-design. Validation of the 
efficacy of this technique would be achieved through statistically significant 
differentiation of Control and DS groups with data obtained from clear or mostly 
clear lenses. Traditional slit-lamp images were acquired to ensure exclusion of 
subjects with extensive lenticular protein deposition. The two images below 
(Figures 4.20 - Control and 4.21 - Down syndrome) exhibit cases where lenses 
were clear yet differences were present in the QLS data as a result of early-stage 
molecular changes. 
 
 
 
Figure 4.20: Slit-lamp image from a 13 y.o. r female Control. The lens appears clear, 
devoid of visible opacities. 
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Figure 4.21: Slit-lamp image from a 20 y.o. male DS patient. The lens appears clear, 
devoid of opacities. 
 
The two studies (Longwood and Peabody) were compared with each other 
and in combination of all data collected from both sites to confirm that there were 
no significant differences in the findings (p-values for scattering intensity were 
0.64 and 0.78 for Control and DS, respectively, and p-values for correlation time 
were 0.99 and 0.92 for Control and DS, respectively). One-factor ANOVA 
analysis was utilized. Combined with the fact that experimental conditions were 
the same and the same ophthalmologists procured the measurements using the 
same QLS device, a lack of statistical significance further validated the common 
inferences. 
Post-translational modification (PTM) of proteins is a primary player in the 
multi-factorial process of molecular aging in the human body. With 
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advancements in healthcare, life expectancy has significantly increased; 
however, so has the incidence of age-related disorders. The problem is 
compounded by the variability in risk factors and phenotypes observed in the 
population. There is also a relationship between the timeline of detection of 
pathology and efficacy of treatment in diseases like Alzheimer’s, one of the most 
prevalent age-related conditions. One of the probable reasons to have 
contributed to the failure of a large percentage of therapies is their administration 
at a late-stage of pathogenesis. Thus, there is need for an early diagnostic for 
signs of accelerated aging to enable timely intervention. A system that has been 
extensively studied to observe and assess post-translational modifications in 
proteins is the lens of the eye. The lens provides an ideal system to detect and 
monitor age-related changes due to spatially organized growth of its fiber cells, 
the absence of protein turnover in the lens fiber cells, and optical accessibility. 
The link between ocular abnormalities and systemic and neurological diseases 
has been extensively researched and well established as well [4, 8, 11, 86, 160, 
161]. Furthermore, in diseases such as Alzheimer’s disease (and Down 
syndrome), changes in the lens have been noted to precede neuropathology. 
The technique of quasi-elastic light scattering offers a sensitive and non-invasive 
approach to probe for molecular alterations in the lens.  
In a cohort of healthy human subjects, age-dependent modifications in the 
lens were assessed in vivo. QLS was found to successfully detect a positive 
correlation between scattered light intensity and correlation time with age, 
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suggesting underlying protein behavior corresponding to PTM’s that cause 
increase in high-molecular weight species. Particle size distributions computed 
for individuals of different ages confirmed this finding. This study highlights the 
potential of QLS to be used as an objective in vivo index to evaluate molecular 
aging. In the future, it can be combined with other health-defining metrics to 
boost prediction power and utilized as a relatively quick quantitative analysis tool 
to identify people at a high-risk of contracting age-dependent disorders.  
The other portion of this chapter focused on the administration of QLS for 
early-detection of Alzheimer disease-related pathology in the lens of Down 
syndrome patients. Through two cross-sectional clinical studies conducted at 
Boston Children’s Hospital in subjects 10–20 years old, we found statistically 
significant differences between the Control and DS groups. These DS studies 
were the first done in vivo in the lens using QLS, and importantly are the first 
instance of any technique’s ability to differentiate the two groups this early in life. 
The index of mean scattering intensity, which is similar to the output from the 
technique of Static Light Scattering, was not able to separate the Control and DS 
groups, and this further emphasizes the need for a method of detection with 
improved resolution. It also helps in understanding the limitations of imaging 
approaches, such as Scheimpflug imaging or Optical Coherence Tomography, 
which essentially also measure the mean intensity similar to static light 
scattering. A previous study using Scheimpflug imaging was unable to discern 
differences between Control and subjects with biomarkers suggesting high risk of 
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Alzheimer’s disease [53]. One of the caveats worth considering in our data is that 
particle size distributions were calculated using a single value of viscosity. The 
lens viscosity has been noted to change with age, and is a factor that needs to 
be incorporated into future studies. 
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Chapter 5  
Comparison of Particle Size Extraction Algorithms 
Quasi-elastic light scattering (QLS) has proven to be fast, reliable, sensitive 
and a relatively easy to employ technique to characterize particles in solutions 
and suspensions for a variety of applications. Post-acquisition analysis of light 
scattering data obtained by QLS provides useful information such as particle size 
distribution of the system under observation. However, extraction of particle sizes 
from QLs data generated from polydisperse samples is an ‘ill-posed’ problem 
requiring sophisticated mathematical analysis. A number of algorithms have been 
developed in an effort to produce optimal approximations [115]. Unfortunately, 
few studies have systematically compared these methods. In this chapter, size 
distributions extracted from QLS experiments are compared using 4 algorithms, 
three of which are commonly applied in literature (Method of Cumulants, Discrete 
Component Analysis, and CONTIN), and one that is relatively recent to the field 
(DYNALS). The study presented here was undertaken to determine the optimal 
algorithm for our research data. Furthermore, to the best of our knowledge, this is 
the first instance of a systematic analysis of these 4 algorithms. We utilized QLS 
data from bimodal suspensions of polystyrene beads to test size extraction 
resolution, and in vitro human lens protein fractions and measurements from in 
vivo human lens to assess the algorithms’ performance in a complex protein 
environment. 
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5.1 Problem Statement 
Consider a suspension of uniform polystyrene beads of known diameter in 
water. A beam of monochromatic laser light passing through this suspension will 
interact with the beads and cause scattering of light. As a result of random 
motion of the bead particles in the suspension, there will be fluctuations observed 
in the scattered light at a point of observation. The temporal correlation of these 
fluctuations is measured in quasi-elastic light scattering (QLS). The measured 
light intensity autocorrelation function (ACF) contains useful information about 
the scattering system, namely, diffusion coefficients. The hydrodynamic radii of 
the scattering particles can then be calculated from the diffusion coefficients 
using parameters specific to the experiment. In the case of a mono-dispersed 
sample of spherical particles in an aqueous medium, the field correlation function 
is defined as in Equation 5.1 [96]: 𝑔 ! 𝜏 =   𝑒!!!!!           (5.1) 
where D is the diffusion coefficient, q is the scattering vector, and τ is the delay 
time. In the case of a polydisperse sample, the autocorrelation function can be 
expressed as in Equation 5.2: 𝑔 ! 𝜏 =    𝐼!  ! 𝑒!!!!!!           (5.2) 
where the summation includes all components of the sample. As discussed in 
Chapter 2, the field autocorrelation function is related to the measured intensity 
autocorrelation function by the Seigert relationship (Equation 5.3). 𝐺! 𝜏 =    𝐼!!  (1+   𝛾𝑔! 𝜏 !)   (5.3) 
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The general aim of analyzing light scattering data is to compute the diffusion 
coefficient(s) from Equation 5.2, which can be re-written for a continuous 
distribution of scattering particles as: 𝑔! 𝜏 =   1 𝐼! 𝐼 𝐷   𝑒!!!!!  𝑑𝐷        (5.4) 
here I(D)dD = N(D)I0(D)dD is the intensity of light scattered by particles having 
their diffusion coefficient in interval [D, D + dD], N(D)dD is the number of these 
particles in the scattering volume, and I0(D) is the intensity of light scattered by 
each of these particles. In order to calculate the diffusion coefficient(s) of the 
scatterer(s), the intensity distribution I(D) or the number distribution N(D) must be 
reconstructed from the measured intensity ACF. Particle size or diffusion 
coefficient distribution extraction is a specific case of the general problem of 
finding inverse solutions. The problem can be stated in the form of an equation 
as [108, 109]: 𝑦! =    𝐹! 𝜆 𝑠 𝜆 𝑑𝜆 +    𝐿!"  !!!!!!! 𝛽! +   𝜖!   (5.5) 
where Fk(λ) are the functions which relate the desired quantity s(λ) to the 
observed data yk, the second term permits the presence of a constant, and the 
third term represents the unknown noise components. Equation 5.5 may arise in 
the following situations: a) imperfect input into the system; b) imperfect detection 
of the phenomena being observed; c) imperfect systems being studied; d) 
indirect measurements, as in the case of light scattering; and e) multicomponent 
systems, where each component generates a characteristic response to the 
input, as observed in polydisperse samples investigated by QLS.  
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The inversion analysis becomes complicate because the problem of 
extraction of particle size distribution from the ACF of intensity fluctuations is 
mathematically “ill-posed”. In an “ill-posed” problem, even if the data is measured 
with very low error, an exact solution may not exist, or alternatively the solution 
might be incorrect. Moreover, an approximate solution is never unique, and there 
may be infinite possible distributions within acceptable error that produce the 
observed data. In addition, the potential solutions may yield unbounded errors 
[96,108,109,115]. In the event that the εk error term in Equation 5.5 is neglected, 
and an analytical ‘exact’ inversion is possible, the solution that gets selected will 
represent one member of an infinitely large solution space that intrinsically 
depends on εk. Due to the unboundedness of the errors, it is likely that the ‘exact’ 
solution will be a poor estimate of the true solution [108]. 
A number of factors contribute to finding the best possible solution. For 
example, reduction of experimental noise and choice of correlator design can 
both decrease the search space by improving quality of measured data [115]. For 
the simplest case of scattering from a mono-disperse sample of uncorrelated 
spherical particles, the a priori expectation of a unimodal distribution with a single 
decay constant can be utilized in direct fit methods [96]. Here, the idea is to use a 
known function model and computationally vary the unknowns until a best-fit 
solution is achieved, as determined by conventional statistical tests (e.g. χ2 test). 
However, this approach can only be used when there is significant a priori 
knowledge of the distribution and very low error in the data, criteria that are not 
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often met with real-world data sets. The inversion problem is further complicated 
in the case of polydispersity, where the effects of different-sized scattering 
particles need to be taken into account [96,108]. The core concept into deriving 
the optimal solution for this approach typically involves finding the ‘smoothest’ 
distribution from among the class of possible solutions. The differences between 
the various methods and algorithms and their implementations are based on how 
this selection is performed [115]. As an example, a commonly used criterion of 
determining ‘smoothness’ requires minimization of the L2 norm of the least 
squares solution with added constraints [115]. The remainder of this chapter 
discusses 4 algorithms that are used to extract particle size distributions from 
measured intensity ACF obtained by QLS. 
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5.2 Algorithm Descriptions 
5.2.1 Method of Cumulants 
Cumulant analysis is one of the earliest methods adopted to estimate 
particle size distributions from ACF’s obtained by QLS [100]. The Method of 
Cumulants (MOC) doesn’t require a priori assumptions regarding the underlying 
distribution and provides an estimation of the distribution’s mean, standard 
deviation, and polydispersity index, skewness. MOC analysis is based on the 
cumulant generating function, which is the natural logarithm of the characteristic 
function (Φ(t)) (Equation 5.6) [169]. 𝑔 𝑡 = ln𝜙(𝑡)          (5.6) 
Here, Φ(t) is defined as the Fourier transform of the probability density function 
(Equation 5.7).  𝜙 𝑡 =    𝑒!"#  𝑃 𝑥 𝑑𝑥!!!!  (5.7) 
The cumulants, κn, can be obtained by power series expansion of g(t) (Equation 
8), and utilization of the Maclaurin series (Equation 5.9). ln𝜙(𝑡) =    𝜅! (!")!!!!!!!  (5.8) ln𝜙 𝑡 = 𝑖𝑡 𝜇!! +    !! 𝑖𝑡 ! 𝜇!! − 𝜇!!  ! +    !!!(𝑖𝑡)! 2𝜇!!  ! − 3𝜇!!𝜇!! + 𝜇!! +⋯  (5.9) 
Here, µn’ are the raw moments of the distribution: κ1 = µ1’; κ2 = µ2’ - µ1’ 2; κ3 = 2µ1’ 
3 – 3 µ1’µ2’ + µ3’, and so on. 
In terms of central moments µn, κ1 = µ = mean or average diffusion coefficient, κ2 
= µ2 = variance, and κ3 = µ3 = skewness, or the asymmetry index of the 
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distribution [115]. In practice, only the first and second moments can be reliably 
estimated using the method of cumulants. As a consequence, this method 
inadequately estimates non-unimodal distributions as shown later in the results 
section (below). 
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5.2.2 Discrete Component Analysis (Multi-Exponential Analysis) 
Another commonly used algorithm used to extract the distribution of 
diffusion coefficients from ACF’s obtained by QLS is called Discrete Component 
Analysis (DCA). This method is also referred to as Exponential Sampling. DCA 
involves discretization of the observed data into a finite number of components 
with different decay rates, with each component expressed as an exponential 
function [169–172] (Equation 5.10). 𝐼 𝑡 =    𝛼!𝑒!!/!!!  (5.10) 
Here, αi is the amplitude of the ith component with a decay time τi, and I(t) is the 
measured intensity of scattered light. The extraction of the amplitudes and the 
decay times from Equation 5.10 is again an ‘ill-posed’ problem with multiple 
possible solutions. Solutions are typically obtained using a non-linear least 
squares minimization approach. The DCA method suffers from the requirement 
of a priori information regarding the sample and is greatly influenced by data 
collection variables. For example, adequate acquisition time and the sample’s 
distribution characteristics (difference in the decay rates of the different 
components need to be adequately different: ~3–5x) are factors to be 
considered. 
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5.2.3 CONTIN: Constrained Regularization Method 
CONTIN is a widely used algorithm that was developed to solve ‘ill-posed’ 
problems such as described by Equation 5.5 [96,108]. In the application of 
photon correlation spectroscopy, CONTIN performs the constrained 
regularization of the inverse Laplace transform to reconstruct the diffusion 
coefficient and hydrodynamic radii distributions from the scattered intensity ACF. 
CONTIN permits three strategies to aid in the reconstruction process: i) absolute 
prior knowledge of the solution space, which confers the constraint of non-
negative solutions and greatly reduces the possible function space to be 
searched, ii) statistical prior knowledge of the mean and covariance of the 
solution, iii) principle of parsimony, regarding the members of the solution space. 
The principle of parsimony states that of all the members of the solution space 
not eliminated by prior knowledge, the one that reveals the least amount of detail 
or information that was not already known or expected should be chosen. While 
this chosen candidate may not have all the detail of the true solution, the detail 
that it does have is necessary to fit the data and therefore less likely to be an 
artifact [108,109]. Conversion of the problem from the form shown in Equation 
5.5 to a quadrature representation of a system of linear algebraic equations 
(Equation 5.11) is the first step performed by CONTIN. 𝑦! = 𝑐!𝐹! 𝜆! 𝑠 𝜆! +    𝐿!"𝛽! +   𝜖!!!!!!!!!!!  (5.11) 
Here, cm are the weights, s(λ) is the solution to be determined at Ng grid points 
λm, and Fk is the function linking the observations yk and s. The second term 
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permits the presence of a constant term, and the errors make up the third term in 
the above equation (11). A more condensed form of Equation 5.10 is given 
below. 𝑦! =    𝐴!"𝑥! +   𝜖!!!!!!  (5.12) 
Here, Nx = Ng + NL, x is a vector containing all the unknowns s(λm) and βi, and 
the matrix A contains the cm, Fk(λm), and Lki terms. 
As mentioned earlier, CONTIN allows the imposition of constraints such 
as non-negativity of the solution space. This can be visualized in Equation 5.12, 
where the arrays D, d, and the constant Nineq can be user-specified. x can be 
thought as representing the vector of elements s(λm), D can be equal to the 
identity matrix I, d can be set to zero, and Nineq can be set equal to Ng (ignoring 
the last NL elements of x to simplify the notation). 𝐷!"𝑥!   ≥   𝑑! , 𝑖 = 1,… ,𝑁!"#$!!!!!  (5.13) 
Even after the imposition of positivity on the inversion problem, there are a large 
number of greatly varying potential solutions. The general concept is to minimize 
the weighted least-squares solution to Equation 5.12 such that the desired 
solution (x) satisfies Equation 5.14. However, this solution is just one member of 
the solution space, and is typically strongly influenced by the error term. 
Considering the large variation among possible solutions, it is highly unlikely that 
the solution will be close to the true solution. 
𝑉 0 =  ∥ 𝑀!!!!  (𝑦 − 𝐴𝑥) ∥!= 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 (5.14) 
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||.|| is the Euclidean or L2 norm, Mε is the positive definite covariance matrix of the 
error, y is the observation vector, and Ax is the model solution.  
CONTIN handles this optimization by employing the principle of 
Tikhonov’s regularization and a parsimonious choice of the regularization term. 
The regularizor penalizes a candidate solution for deviations from behavior 
expected on basis of statistical prior knowledge and parsimony. In Equation 5.15, 
the relative strength of the regularizor is determined by α, the regularization 
parameter. 
𝑉 𝛼 =  ∥ 𝑀!!!!  (𝑦 − 𝐴𝑥) ∥!  +   𝛼!   ∥ 𝑟 − 𝑅𝑥 ∥!  = 𝑚𝑖𝑛𝑖𝑚𝑢𝑚 (5.15) 
Selection of an appropriate regularization term is influenced by the requirement 
of choosing the ‘simplest’ member of the solution space, one that smoothens the 
distribution without introducing artifacts such as extra peaks. CONTIN uses the 
regularizor shown in Equation 5.16. ∥ 𝑟 − 𝑅𝑥 ∥!=    𝑠!!(𝜆) !𝑑𝜆!!   (5.16) 
Selection of the regularization parameter, α, is done by gradually increasing the 
value and comparing against the value of α0, minimum value of the weighted 
sum of squared residuals (first term on the right hand side of Equation 5.15).   
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5.2.4 DYNALS: Non-Negative Truncated Singular Value Decomposition 
DYNALS is a commercial software package for particle size distribution 
analysis of photon correlation spectroscopy data. The DYNALS algorithm is 
based on truncated singular value decomposition (SVD) with a non-negative 
constraint [115]. The first step, in this algorithm, involves discretization of the 
solution range into N number of logarithmically-spaced rectangular columns, 
resulting in a system of M linear equations with N unknown coefficients {xi} 
(Equation 5.17). M is the number of correlator channels and hence the set of 
points at which the behavior of the ACF is known, and Γ is the decay rate 
constant. 𝑔(!)(𝑡!) =    𝑥!    𝑒!!!!!!!!!!   𝑑Γ, 𝑖 = 1…𝑀, 𝑘 = 1…𝑁!!!!   (5.17) 
or in a compact form: Ax = g 
𝑎!" =    𝑒!!!!  𝑑Γ =    1𝑡!    𝑒!!!!!!! −   𝑒!!!!! , 𝑖 = 1…𝑀, 𝑘 = 1…𝑁  !!!!!!  𝑔! =   𝑔 ! 𝑡! , 𝑖 = 1…𝑀       (5.18) 
The discretization of the solution range into histogram columns bears 
resemblance to the method of histograms [115]. The difference lies in DYNALS’ 
ability to use a large number of columns to represent the distribution. In the 
method of histograms, stabilization of the problem is achieved by restricting the 
number of columns used to typically ten to fifteen. This limitation is related to the 
rate of decay of singular numbers of the system matrix A [115]. A singular value 
is the square root of the eigenvalue of a system. In DYNALS, stabilization is 
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achieved by using constrained truncated singular value decomposition along with 
minimization of the L2 norm to arrive at an optimal reconstruction of the diffusion 
coefficient distribution having the smallest energy. The SVD of the matrix A 
(Equation 5.18) is defined as A = USVT, where U and V are orthogonal matrices 
and S is a diagonal matrix with non-negative singular values of A. U and V are 
composed from the eigenvectors of A. The sensitivity of the solution to errors in a 
given data is defined exclusively by the matrix S [115]. The advantage of using 
SVD in handling this ‘ill-conditioned’ problem is that it easily allows extraction of 
only the most stable or reliable information. This is done by replacing the matrix 
S by S+, where the positive singular numbers are sorted by descending order.  
The art of using the truncated SVD is to find a compromise (an 
appropriate number of singular values) between the residual norm and the 
solution norm [115]. In order to implement the minimization of the residual norm 
under the constraint of non-negativity, only those singular values that significantly 
exceed the error are used. This constraint ensures that the solution is not 
affected by noise in the measurement. 
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5.3 Results 
5.3.1 Method Validation Using Monodisperse Suspensions of Polystyrene 
Beads 
The first step in comparison of the 4 algorithms discussed in the preceding 
section was validating their implementation using monodisperse aqueous 
suspensions of polystyrene beads of known sizes. For each bead sample, the 
correlation time and hydrodynamic radius was extracted from the measured 
intensity autocorrelation function. Three replicate data sets were used; each set 
contained 5 measurements and each measurement was performed with an 
acquisition time of 10 seconds. The output from the different algorithms was 
compared against theoretical values. Figure 5.1 shows the correlation time for 
the different bead sizes computed using the different algorithms. Theoretical 
values were calculated using a viscosity of 1 cP, wavelength of 780 nm, 
refractive index of 1.33, and a scattering angle of 110.6° (Details regarding QLS 
theory and setup are discussed in Chapter 2). For Discrete Component Analysis, 
the a priori assumption of 1 peak was used. 
In Figure 5.2, the extracted hydrodynamic radii for the various bead sizes 
are plotted against expected sizes.  
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Figure 5.1: Linear increase in correlation time with (known) polystyrene bead radius. 
Each data point represents mean ± standard deviation. 
 
 
 
Figure 5.2: Empirically calculated hydrodynamic radii for all the algorithms shows high 
degree of correlation with theory (known bead sizes). Each data point represents mean 
± standard deviation. 
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All 4 algorithms tested produced comparable results and agree with 
theoretical values for correlation time and when compared against known bead 
radii. These findings suggest that the algorithms had been correctly implemented 
and yield comparable solutions for unimodal analysis.  
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5.3.2 Particle Size Resolution From a Bimodal Distribution of Polystyrene 
Beads 
Particle size extraction from a non-unimodal sample was the next step in 
comparison of the methods. As discussed earlier in this chapter, data analysis of 
polydisperse and/or multi-modal distributions is a significantly complex problem. 
In order to compare the methods, an aqueous suspension of a mixture of 11 nm 
and 100 nm beads was used. The beads were mixed to give a scattering 
intensity ratio of roughly 1:1. Three data sets, each generating an autocorrelation 
function, were analyzed. A data set consisted of 15 replicates, each with an 
acquisition time of 10 seconds. Parameters used in the analysis were: 
wavelength – 780 nm, scattering angle – 140.5°, viscosity – 1 cP, refractive index 
– 1.33 (Details regarding QLS theory and setup are discussed in Chapter 2).  
The calculated correlation times and hydrodynamic radii from the 4 
methods are shown in Figures 5.3 and 5.4 respectively. In theory, the correlation 
times for the two bead sizes should be 0.126 ms and 1.146 ms for aqueous 
suspensions in water at room temperature. The method of cumulants fails to 
resolve the two peaks in the sample, producing an output in between the two 
sizes (22 nm and 0.249 ms). Surprisingly, even with the a priori assumption of 2 
peaks, DCA is unable to accurately resolve the two components, giving the same 
correlation time and hydrodynamic radii for both peaks (i.e., 0.33 ms and 27.8 
nm). By contrast, both CONTIN and DYNALS produced results that were close to 
expected values. CONTIN calculated correlation times of 0.135 ms and 1.161 ms 
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and resolved peaks into sizes of 11.75 nm and 101.24 nm. DYNALS’ outputs for 
correlation times were 0.13 ms and 1.07 ms and the two peaks were 11.3 nm 
and 94 nm. In Figure 5.5, the extracted size distribution from one of the data sets 
is presented. Expected peak positions at 11 nm and 100 nm are denoted by the 
black vertical dashed lines. Cumulant analysis is depicted by blue vertical lines 
on the plot (Figure 5.5), with the first cumulant (mean value) shown with higher 
amplitude than the markers on its left and right. This amplitude is only for 
visualization purposes and does not signify difference in contribution to the 
results. The markers on the left and right off the mean take into account the 
standard deviation and skewness of the distribution according to the following 
relationships. 
If Skewness >= 0.0, 
MarkerLeft = Mean – Std; MarkerRight = Mean + Std * (1 + Skewness) 
If Skewness < 0.0, 
MarkerLeft = Mean – Std * (1 - Skewness); MarkerRight = Mean + Std 
This form of presentation for cumulant analysis is followed through the remainder 
of the results. The output for DCA is marked by the vertical green line at the 
calculated hydrodynamic radius and is the same value for both components. Size 
distributions generated using CONTIN and DYNALS are centered close to the 
expected value providing resolution of the bimodal distribution. 
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Figure 5.3: Correlation times calculated by DYNALS and CONTIN are in agreement with 
theoretical values, while Cumulant Analysis fails to resolve the two peaks, and DCA 
produces incorrect values. 
 
 
Figure 5.4: Extracted hydrodynamic radii from the 4 methods plotted against expected 
theoretical values. 
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Figure 5.5: Particle size distributions for a mixture of 11 nm and 100 nm radii beads 
computed using the different algorithms 
 
From this analysis, the limitations of the method of cumulants and discrete 
component analysis are apparent. The former produces an expected output: a 
mean value of correlation time and hydrodynamic radius of the sample 
distribution located between the two components. This result illustrates the 
inability of the cumulants method to be used for analysis of light scattering data 
from a non-unimodal distribution, which is not a failure of the method per se but 
rather a limitation in design. In the case of DCA, even when prior information of 2 
components is provided, the model is unable to correctly separate the 
distributions. Moreover, with both these methods, the output constitutes discrete 
values rather than a smooth distribution, which further highlights the reduced 
information content compared with CONTIN and DYNALS analyses.  
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5.3.3 Particle Size Extraction from In Vitro Samples of Water-Soluble 
Human Lens Proteins 
Experimental biological data, such as cellular constituents, are typically 
characterized by an unknown number of components of varying sizes, and 
extraction of the particle size distribution is extremely challenging. This situation 
was represented by analyzing light scattering ACF’s from three replicate samples 
of water-soluble human lens proteins at a concentration of 1 mg/ml and at three 
time points along the course of the experiment described in Section 1 of Chapter 
3. These samples were chosen because they describe: i) typical in vitro data sets 
that we have analyzed in our experiments, ii) they model the cytosolic protein 
milieu found in the human lens in vivo, iii) examining the water-soluble fraction of 
human lens proteins provides a useful, practical, and relevant system to study 
efficacy of particle size extraction algorithms, and iv) conducting the analyses at 
different time points along the course of the experiment allows for employment of 
the methods on different underlying particle distributions. 
The water-soluble portion of human lens proteins has been shown to 
contain a multitude of different protein species existing in a spectrum of 
molecular weights. Over the course of the experiment, there are observed 
changes in the correlation time and intensity, which would indicate a possible 
change in the underlying protein size distributions (see Chapter 3 for discussion 
and results). Parameters used for the analysis were as follows: wavelength – 780 
nm, viscosity – 1 cP, refractive index – 1.33, and a scattering angle of 140.5o. 
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Figure 5.6 shows the results of size extraction from the samples from day 7 of 
the experiment. Cumulant analysis (Figure 5.6a) yields a mean of 33.5 nm for the 
hydrodynamic radii of the three replicates. For DCA, the a priori assumption of 4 
exponentials, which was the maximum possible, was used. In Figure 5.6b, we 
see the presence of peaks in the <10 nm, 10–100 nm, 200–1000 nm, and a large 
one close to 10 µm. Note the large variance (30–80%) between the peak values 
for different samples. The results of CONTIN analysis are presented in Figure 
5.6, Panel C. The high degree of overlap observed between size distributions for 
the three replicates suggests confidence in the analysis. The peaks are centered 
at a mean value of 29 nm. Figure 5.6d shows the three size distributions 
computed by the SVD algorithm of DYNALS, and these show a high degree of 
overlap as well. The distributions appear to have two slightly distinct populations 
of protein sizes, with one peak centered at 12.5 nm and the other at 186 nm.  
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Figure 5.6: Particle size extraction from 3 replicates of water-soluble human lens 
proteins from day 7 of the experiment. a) Method of Cumulants; b) Discrete Component 
Analysis; c) CONTIN, d) DYNALS 
 
Particle size distributions extracted from the 4 methods for day 56 of the 
experiment are presented in Figure 5.7. The method of cumulants (Figure 5.7a) 
calculates the mean of the underlying distribution to be centered at 23.1 nm. 
DCA (Figure 5.7b) shows presence of a very small component <0.5 nm, which is 
likely an artifact (since it is at the detection limit of QLS). In Figure 5.7b, there 
also components calculated in the 10–20 nm, 100–300 nm ranges, and one at 
around 1000 nm. Size distributions computed by CONTIN show overlap between 
a) 
c) 
b) 
d) 
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two of the three replicates (Figure 5.7c). Resolution of the peaks is also markedly 
different between samples 1 and 3 compared with sample 2. Peaks are found at 
values of roughly 2 nm, 20 nm, and between 250–400 nm. From the DYNALS 
distribution analysis (Figure 5.7d) for day 56, we see significant overlap between 
the three replicates, with a primary peak close to 20 nm, and a smaller peak at 
around 1 nm.  
 
 
Figure 5.7: Particle size extraction from 3 replicates of water-soluble human lens 
proteins from day 56 of the experiment. a) Method of Cumulants; b) Discrete Component 
Analysis; c) CONTIN, d) DYNALS 
 
a) 
c) 
b) 
d) 
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The final time point assessed was for day 154 of the experiment. Here we 
see cumulant analysis (Figure 5.8a) produce a mean value of 36.5 nm for the 
hydrodynamic radii of the three replicates. DCA, using a priori assumption of 4 
exponentials, provides a component output at ~0.5 nm (likely an artifact) and two 
more in the 10–100 nm range. At this time point, CONTIN (Figure 5.7c) and 
DYNALS (Figure 5.7d) both produce outputs that have significant correlation 
between the 3 replicates, and the hydrodynamic radii distribution consists of one 
major peak. For CONTIN, the mean peak position is calculated to be 42.5 nm, 
and for DYNALS, it is calculated to be 42.7 nm. 
 
 
Figure 5.8: Particle size extraction from 3 replicates of water-soluble human lens 
proteins from day 154 of the experiment. a) Method of Cumulants; b) Discrete 
Component Analysis; c) CONTIN, d) DYNALS 
a) 
c) 
b) 
d) 
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From the results, we can conclude that the method of cumulants provides 
a crude representation of the distribution by computing its mean, standard 
deviation, and skewness indices. At all the time points, the mean value was close 
to peaks of interest calculated by the other methods. However, due to lack of a 
distribution output and inability to resolve non-unimodal distributions, there is a 
general reduction of available and usable information compared to other 
algorithms. Some of these limitations also apply to discrete component analysis. 
While DCA calculated components that coincided with peaks seen in distribution 
analyses, this technique appears sensitive to noise in the data. This is 
demonstrated by the presence of peaks with relatively high amplitudes present in 
size ranges at or below the detection limit of QLS. Moreover, DCA requires a 
priori information about the distribution, a constraint that severely limits its 
usefulness in an experimental setting with typically unknown sample 
characteristics. CONTIN is a widely used method for size distribution analysis, 
and as seen from the data, this method generally performs well with 
polydisperse, multi-modal distributions. However, the stability in providing the 
optimal solution appears to be compromised in the case of a high degree of 
polydispersity (e.g. Figure 5.7c). The distribution for one of the replicate samples 
does not corroborate with the other two replicates. When data from time points 
before and after day 56 were analyzed, there was overlap between computed 
distributions for all three replicates. Since the same data sets were used for all 
methods, this suggests that CONTIN was unable to provide the optimal solution 
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for this data. The SVD algorithm of DYNALS performed effectively in extracting 
size distributions from the lens protein samples at all the time points. In the case 
of samples with a mostly unimodal distribution, results from DYNALS and 
CONTIN were in agreement. For the day 56 samples, size distributions 
calculated using DYNALS overlapped well among the replicates. 
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5.3.4 Particle Size Extraction from In Vivo Measurements from a Human 
Lens 
The final method for comparison of the 4 algorithms – Method of 
Cumulants, Discrete Component Analysis, CONTIN, and DYNALS, consisted of 
3 data sets obtained by QLS measurements from the lens of the same individual 
(31 y.o. female) on different days. Experimental conditions were the same: 
wavelength – 780 nm; scattering angle – 110.60; viscosity used – 5.74 cP; 
refractive index – 1.4. A data set comprised of 5 replicates with each replicate 
having an acquisition time of 0.5 seconds (Details regarding the QLS setup are 
presented in Chapter 2).  
Using this in vivo QLS data for algorithm comparison provides another 
analysis setting with experimental noise, an observation system with a wide 
range of protein sizes and conformations, and are typical data obtained from in 
vivo measurements from the human lens. Moreover, this data constitutes results 
obtained in the clinical study discussed in Chapter 4 – Section 1, and thus, 
understanding the size distribution analysis is relevant to this thesis research. 
Figure 5.9 presents the results from the different methods. Cumulant analysis 
produced a mean value of the distributions centered at 20.3 nm (Figure 5.9a). 
Again, due to lack of knowledge of the underlying distribution, an a priori 
assumption of 4 peaks (maximum) was used for DCA. Figure 5.9b shows two 
major clusters of components: centered close to 1 nm and 100 nm. CONTIN 
analysis also produced a size distribution comprising of 2 peaks – one positioned 
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close to 1 nm and the other close to 100 nm. This distribution pattern was further 
confirmed by DYNALS, with the two calculated peak positions near 1 nm and 100 
nm  
 
Figure 5.9: Particle size distribution computed from 3 sets of data from the same 
individual (31 y.o. female). 
 
 
The comparison of extracted size distributions from in vivo sets of data 
underlines recurring differences in the algorithms. CONTIN and DYNALS both 
reconstruct a smooth distribution of the particle sizes rather than discrete values, 
thus providing granular information about the system under observation. In this 
a) 
c) 
b) 
d) 
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data, MOC again fails to resolve the distribution into 2 primary components (as 
validated by correspondence between the other methods) and calculates the 
mean to be a value between the two peaks. DCA does distinguish the data into 
two clusters of components, but it also requires a priori information of the 
distributions. CONTIN and DYNALS, in general, provide comparable results on 
these data. 
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The objective of this chapter was to discuss and systematically compare 4 
algorithms that compute the particle size distribution from the scattered light 
intensity ACF obtained using QLS. Of the 4 algorithms, MOC, DCA, and CONTIN 
are widely used choices, while DYNALS is a relatively recent application to this 
area of study. Using known unimodal suspensions of polystyrene beads, we 
noted that all 4 methods were accurately implemented. 
A significant level of complexity is added to size extraction analysis when 
the sample under observation comprises of different sized components. We 
compared the performance of the algorithms using QLS data obtained from a 
bimodal suspension of 11 nm and 100 nm radii polystyrene beads. From the 
results, it was observed that MOC and DCA were not able to resolve the particle 
sizes accurately. Since MOC provides a mean value of the sample’s underlying 
distribution, this algorithm’s output, expectedly, was between the two known 
bead sizes. A limitation of the method of DCA is that a priori information about 
the distribution is required. Surprisingly, even with a priori knowledge of 2 peaks, 
DCA could not resolve the QLS-derived ACF into its two components. By 
contrast, CONTIN and DYNALS were able to resolve the ACF into its 2 
underlying components. 
The in vitro QLS data sets discussed in Chapter 3 were obtained from the 
complex mixture of human lens proteins and extracting the size distributions of 
this polydisperse protein solution presents a relevant analysis problem. Similarly, 
the in vivo QLS ACF’s acquired from a human lens are representative of typical 
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data, and deriving the size distribution from these ACF’s are valuable in 
understanding the underlying protein environment. 
The findings from this study can be summarized as follows: 
i) MOC and DCA provide a coarse estimate of the sample’s particle size 
distribution since these algorithms compute discrete values, rather than a 
distribution. 
ii) The analysis of non-unimodal data is a handicap for MOC. 
iii) DCA requires a priori knowledge of the sample distribution, a factor that 
limits this algorithm’s utility in unknown experimental data sets. 
iv) CONTIN and DYNALS typically produce comparable output and are 
effective in extracting particle size distributions from polydisperse 
samples. However, as observed for one of the in vitro data sets (Fig. 7c), 
CONTIN’s capability might be compromised when the degree of 
polydispersity is high. 
Particle size distributions, extracted from QLS-derived ACF’s, are useful for 
understanding molecular changes that produce the measured scattering 
intensity, and provide granular knowledge about the population of scattering 
particles. Through these observations, we conclude that DYNALS represents the 
best choice for size distribution analysis of ACF’s obtained by QLS from 
multimodal, polydisperse samples.  
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Conclusions 
 
The overarching goal of this thesis research was to assess protein 
changes in the long-lived lens crystallins as a consequence of age, pathogenic 
protein mediation, and physiologically relevant perturbations (e.g. radiation, 
oxidative stress, metals) using quasi-elastic light scattering (QLS) in vitro and in 
vivo. 
Through in vitro experiments, we noted that long-term (approximately one 
year) modifications in a complex polydisperse mixture of water-soluble human 
lens proteins, as a model system for the aging lens in vivo, were observable 
using QLS. Changes in QLS were corroborated independently by Protein Gel 
Electrophoresis and Transmission Electron Microscopy, and corresponded with 
changes in underlying protein distributions with respect to hydrodynamic radii. 
We also determined that long-term effects on lens proteins upon exposure to 
radiation, oxidative stress, Zn2+, and amyloid-β potentiated interactions were 
detectable and consistent with reported changes in vivo, namely, perturbations 
cause alterations in lens proteins leading to increased aggregation and loss of 
structural order. 
In a clinical study conducted at Boston Children’s Hospital (BCH) on 
healthy control subjects 5–61 years of age, we successfully detected age-related 
molecular changes by QLS. Differences among particle size distributions of the 
lens protein population as a function of age suggested an increase in high 
molecular weight proteoforms. Results obtained from two replicate clinical 
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studies at BCH sites demonstrated the ability of QLS to detect Alzheimer’s 
disease-related protein changes in the lenses of Down syndrome (DS) subjects. 
These two studies were the first instances of the clinical application of QLS for 
detection of lens protein changes in DS. We noted statistically significant 
differences between DS and age-matched control subjects in the 2nd decade of 
life, which is more than a decade earlier than previous studies using imaging 
techniques. 
Comparison of four algorithms that are used to extract particle size 
distributions from QLS-derived autocorrelation functions (ACF) highlighted 
certain limitations of some of these algorithms. Upon performing a systematic 
comparison using multiple experimental data sets, DYNALS algorithm was 
determined to be the optimal choice for particle size extraction from QLS data 
acquired in our work. This is the first instance, to the best of our knowledge, that 
these four algorithms have been methodically compared. 
As a consequence of the discrepancy between chronological age and 
biological age, there is a quest for biological markers of aging. We propose the 
application of QLS-detectable protein changes in long-lived lens crystallins as a 
non-invasive, quantitative, sensitive, and accessible biomarker of molecular 
aging. The QLS output could be combined with biologically relevant estimates of 
health, such as blood pressure, cholesterol levels, genetics, and lifestyle choices 
to classify potential individuals at high-risk of aging or developing age-related 
disorders. Longitudinal studies that then follow such high-risk individuals will be 
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beneficial in further exploration of QLS’s efficacy. Findings from such long-term 
studies could then be compared with other examinations that determine disease 
pathology for the purpose of validation.   
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